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1. De uitwisseling van T4 uit het maternale plasma met het foeto-placentaire com-
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CHAPTER 1 
GENERAL INTRODUCTION 
General Introduction 
1.1. THYROID HORMONE METABOLISM 
Thyroid hormone action 
Thyroid hormone is active throughout the whole body. Numerous biological effects 
have been described. During fetal life and childhood thyroid hormone plays an 
important role in development and growth. Throughout life thyroid hormones are 
responsible for regulation of the metabolic state. 
The thyroid produces mainly thyroxine (T4), and to a much lesser extent 3,5,3'-
triiodothyronine (T3). The greater part of T3 is formed in the different organs by 
monodeiodination of T4. T3 has been shown to be the biologically active form of 
thyroid hormone. The working mechanism of T3 is similar in all organs; T3 exerts it 
action by nuclear T3 receptors. After binding of T3 the T3-receptor complex interacts 
with the promotor of various genes by binding to a thyroid hormone response ele-
ment, resulting in regulation of transcription of the target genes and influencing the 
specific mRNA synthesis of many target genes (47). 
Peripheral thyroid hormone metabolism 
In several tissues T4 and T3 are metabolized via different pathways. The most im-
portant is deiodination, especially because biologically inactive T4 is metabolized 
into biologically active T3 via this route. In the rat about 40 % of T3 is secreted by the 
thyroid, wheras about 60 % is derived from extrathyroidal conversion of T4 (50, 57, 
58, 60). 
T4 can be deiodinated in the outer ring (in the 3' or 5' position, outer ring deiodina-
tion; ORD) or the inner ring (in the 3 or 5 position, inner ring deiodination; IRD). The 
ORD of T4 results in T3 and is regarded as the activating step. The IRD of T4 results 
in reverseT3 (rT3), which is the so-called inactivation step. The different deiodination 
reactions are shown in Fig. 1. Three different deiodinase enzymes are known (29, 
33). Type I iodothyronine deiodinase (ID-I) is a selenocysteine containing, nonselec-
tive enzyme, which is competitively inhibited by propylthiouracil (PTU). Both the 
inner and the outer ring can be deiodinated by this enzyme. It is responsible for both 
the production of T3 as well as the clearance of mainly rT3 in the liver. ID-I has been 
found in liver, kidney and thyroid. rT3 is the preferred substrate, the conversion of rT3 
to 3,3'-T2 is roughly 103 times more efficient than the deiodination of T4 and T3 (28). 
Type II iodothyronine deiodinase (ID-II) acts only on the outer ring and catalyzes the 
conversions of T4 to T3 and rT3 to 3,3'-T2. The enzyme is not inhibited by PTU. It is 
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present in the pituitary, central nervous system and brown adipose tissue. In these 
tissues, ID-II is responsible for the local supply of T3 (26). 
Type III enzyme (ID-Ill) catalyzes the formation of rT3 from T4 and the formation of 
3,3'-T2 from T3. The highest levels of this enzyme are found in the central nervous 
system, placenta and skin (63). 
Other pathways for the metabolism of thyroid hormones are conjugation with either 
glucuronic acid or sulfate. Conjugation of thyroid hormones increases the water-
solubility and thus facilitates their excretion via bile (62). Sulfation enhances type I 
deiodination of T3 (48). A relatively minor role in thyroid hormone metabolism is 
played by side chain deamination and decarboxylation as well as ether-link cleavage 
(32). 
outer ring inner ring 
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ID-I 
ID-II 
Figure 1: Deiodination pathways of thyroid hormones. ID-I, type I deiodinase; ID-II, type I 
deiodinase; ID-Ill, type III deiodinase. 
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Thyroid hormone synthesis in the thyroid 
Thyroid hormone is synthesized in the thyroid gland, an endocrine organ located in 
the lower part of the throat around the trachea. The functional unit of the thyroid 
gland is the follicle, a single layer of follicular cells surrounding thyroglobulin (Tg)-
containing colloid. T4 and T3 can be formed by coupling iodinated tyrosylresidues 
(monoiodotyrosine and diiodotyrosine) in the Tg molecule. The iodination reaction of 
the tyrosyl-residues takes place on the apical membrane at the colloid site and is 
catalyzed by thyroid peroxidase. The iodinated Tg, containing T4 and T3, is stored in 
the colloid lumen. When thyroid hormone is required the Tg molecule reenters the 
follicular cell. Thyroid hormones, released by hydrolysis of the Tg molecule in pha-
golysosomes, enter the circulation (61 ). 
Role of iodide in thyroid hormone synthesis 
Iodide is an essential element for the synthesis of thyroid hormone. Inorganic iodide 
is transported from the blood into the thyroid follicular cell by means of Na7l" sym-
port (34). The most important iodide-concentrating tissues in vertebrates are thyroid, 
placenta, salivary glands and gastric mucosa. The thyroid is the only organ which is 
able to organify accumulated iodide (67). The transport of iodide into the thyroid 
gland is an active process (61). This process is regulated by thyroid-stimulating 
hormone or thyrotropin (TSH) (61 ) and the thyroidal blood flow (2). 
Regulation of thyroid hormone production 
Thyroid hormone production by the thyroid gland is stimulated by TSH, which is 
secreted by the anterior pituitary gland. The synthesis and secretion of TSH are 
stimulated by thyrotropin-releasing hormone (TRH) from the hypothalamus. Both T4 
and T3 exert a negative feedback on TSH synthesis and release, directly at the 
pituitary level and indirectly at the hypothalamic level by reducing the secretion of 
TRH (68). TSH binds to a TSH-receptor on the basal membrane of the thyroid cell 
and stimulates thyroid hormone synthesis at many different levels. Thyroidal iodide 
uptake as well as the synthesis and release of thyroid hormones is under the control 
of TSH (69). Since thyroid function is not abolished completely after hypophysec-
tomy, there must be an internal autoregulatory system within the thyroid gland (49). 
The local production of T3 from T4 in several organs is regulated by the activity of the 
deiodinase enzymes and the availability of the precursor, T4. During hypothyroidism 
the ID-I activity in liver and kidney is decreased, while the ID—II activity in brain 
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increases. The effects of hyperthyroidism are just in the opposite direction. Iodine 
deficiency does not affect ID-I activity in liver and kidney, while ID-II activity in the 
brain is increased (5, 25, 31 ). In the brain the aim of regulation is to reach homeo-
stasis of the intracellular T3 level. 
Transport of thyroid hormones 
Thyroid hormones secreted into the blood are almost entirely bound by specific 
binding proteins in the plasma. In humans thyroxine-binding globulin (TBG) is the 
most important binding protein, while in rat albumin is the most abundant binding 
protein for thyroid hormones. The free hormone fraction is metabolically active at the 
tissue level. In normal human serum, approximately 0.02 % of total T4 and 0.2 % of 
total T3 is free (53). Thyroid hormones enter the cell by means of specific transport 
proteins in order to exert their hormonal effects (12). 
1.2. MATERNAL THYROID HORMONE METABOLISM DURING PREGNANCY 
The maternal thyroid 
During pregnancy thyroidal activity is stimulated by TSH and human chorionic 
gonadotropin (hCG) (27). In humans hCG levels are high mainly in the first half of 
gestation (4), whereas slightly increased TSH levels occur during the second half of 
gestation (22). 
Enlargement of the maternal thyroid is common during normal human pregnancy 
(22). The uptake of radioiodide, expressed as percentage dose, is increased (1, 18). 
However, the availability of iodide for the maternal thyroid is decreased, due to 
increased renal clearance (1) and transport to the feto-placental complex during the 
late phase of gestation (18). Iodide is transported actively through the placenta (31). 
In the rat a decrease in uptake of 131l by the maternal thyroid at the end of gestation 
has been described (16, 21, 24). 
Maternal thyroid hormone concentrations and metabolism 
Human pregnancy is accompanied by a rise in TBG and total T4 and T3 (18, 22). 
However, the level of free T4 is only decreased slightly at the end of gestation (4, 7, 
28, 65). Plasma TSH is increased slightly in more than 80 % of the near-term preg-
nant women, even though levels remain in the normal range (22). 
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In rat plasma T4 and T3 concentrations are decreased markedly during gestation (9, 
41). The free fraction of T4 is increased at the end of gestation (21), resulting in free 
thyroid hormone concentrations that stay within the normal range, just as in humans. 
Despite the considerable decrease in plasma T4 and T3 values, plasma TSH in the 
rat remains constant or is only elevated slightly at the end of gestation (9, 20, 30). 
It has been reported that the clearance of T4 from the plasma is enhanced in preg-
nant rats (21). Both the extra-thyroidal T4-pool and the turnover of T4 are increased 
near-term. The secretion rate for T4 is increased markedly just prior to term but equal 
to control values until 1 day before parturition (35). This has also been shown in 
mice. The fractional turnover of plasma T4, the volume of distribution of T4 and the 
T4-secretion rate were all elevated in pregnant mice compared to virgin mice (66). 
Rat studies by the Madrid group have shown that in all tissues, except T3 in the 
brain, T4 and T3 concentrations are decreased at the end of gestation. T3 in the brain 
stayed within the normal range because of an increase in the local production of T3 
from T4 as a result of an increase in ID-II activity (9, 38, 40, 43). No significant 
alteration in monodeiodination in liver homogenates from pregnant rats at the end of 
gestation was found by Yoshida et al. (70). However, a slight increase in hepatic ID-I 
activity in the near-term pregnant rat was described by Calvo et al. (9). 
Maternal thyroid hormones and fetal development 
It is well established that thyroid hormones play an important role during develop-
ment, especially of the central nervous system. Until two decades ago it was gene-
rally accepted that there is no transport of maternal T4 and T3 to the fetus (19). 
However, convincing evidence for humans as well as rats has been presented that 
there has to be a transport of maternal thyroid hormones to the fetus. Even before 
the onset of fetal thyroid function T4 and T3 can be detected in rat (43, 44) as well as 
human embryos (6, 17). The concentrations of T4 and T3 in embryonic tissues from 
thyroidectomized dams were undetectable before the onset of fetal thyroid function 
and were still reduced in some tissues near-term, despite the onset of fetal thyroid 
function (43, 55). Even during normal pregnancy the maternal to fetal transfer of T4 
continues until term (37, 39). 
In the human fetus with an impaired thyroid neurological damage can be prevented 
by initiating thyroid hormone treatment within a few days of birth. This implies that 
during fetal development the supply of maternal thyroid hormones was sufficient to 
achieve a normal development of the central nervous system (64). 
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1.3. IODINE DEFICIENCY 
Since iodine is an essential element for thyroid hormone synthesis iodine deficiency 
affects the production of thyroid hormones, which results in alterations in thyroid 
hormone metabolism. Iodine intake is insufficient in large areas of the world. In case 
of severe iodine deficiency this results in a broad spectrum of iodine deficiency 
disorders, including miscarriage, stillbirth, congenital anomalies as well as the more 
familiar goiter, cretinism, impaired brain function and hypothyroidism in children and 
infants (23). Many effects of iodine deficiency are the result of impaired maternal 
thyroid functioning during pregnancy. In fact, even the effects of marginal iodine 
deficiency on maternal thyroid hormone metabolism and fetal development are 
unknown. 
Effects of iodine deficiency on thyroid hormone metabolism 
In nonpregnant rats it has been shown that during severe iodine deficiency the 
weight of the thyroid increases markedly, while the iodine content of the thyroid 
decreases rapidly. The T3-to-T4 ratio in the thyroid is increased (52, 56). Studies of 
10-day-old rats have shown that the thyroidal uptake of iodide, as percentage dose, 
was considerably higher in iodine-deficient than in control rats (71). The plasma T4 
level is decreased and plasma TSH is increased, while circulating T3 levels remain 
normal. The activities of the thyroid hormone-dependent enzymes alpha-glycero-
phosphatedehydrogenase and malic enzyme in liver are significantly decreased 
(56), implying that the hepatic T3 levels are decreased during iodine deficiency. 
Despite an increase in ID-II activity tissue T3 levels in the brain are lower during 
iodine deficiency which results in cerebral hypothyroidism. This is caused by the 
decreased availability of T4 for the local production of T3 (46). 
Iodine deficiency during pregnancy 
In areas of marginal iodine intake pregnancy constitute a goitrogenic stimulus (22). 
In the pregnant rat iodine deficiency results, just as in the nonpregnant rat, in an 
increase in the weight of the thyroid and a decrease in plasma T4. This decrease in 
plasma T4 is in addition to the decrease caused by pregnancy. (15, 45). 
When iodine deficiency is severe enough to cause very low maternal plasma T4 
values, embryonic and fetal tissues become deficient in T4 and T3 both before and 
after the onset of fetal thyroid function (15, 45). Despite an increase in ID-II activity 
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in the fetal brain normal T3 values cannot be achieved (45). 
1.4. MATERNAL HYPOTHYROIDISM 
Maternal hypothyroidism can be considered a rather common problem, especially 
since it is clear that maternal thyroid hormones are of great importance for a normal 
development of the fetal central nervous system. Untreated or inadequately treated 
hypothyroid women are less fertile and exhibit an increased risk of spontaneous 
abortion (3). For the children of mothers who were hypothyroid during pregnancy the 
incidence of behavioral and neurological disorders is high (36). 
The thyroidectomized rat is an appropiate model for maternal hypothyroidism in rats. 
Thyroidectomy results in very low T4 and T3 levels in maternal plasma and tissues 
(41, 42, 51, 55). Before the onset of fetal thyroid function T4 and T3 are not detect-
able in the embryo (43). At the end of gestation fetal plasma T4 and T3 values have 
normalized (41, 51, 55). Most fetal tissues still exhibit decreased T4 and T3 levels on 
day 20 of gestation, but the difference with respect to the control fetuses is already 
much smaller than on day 18 (55). 
In the thyroidectomized mother treated with methimazole, maternal as well as fetal 
hypothyroidism will occur. In this severe situation it has been shown that only T4, and 
not T3, is able to mitigate T3 deficiency in the fetal brain (8, 41 ). This means that 
maternal T4 is especially important for the normal development of the fetal brain. 
1.5. OUTUNE OF THIS THESIS 
Thyroid hormones, especially T4, transported from mother to fetus, are of great 
importance for the development of the central nervous system. In most studies the 
point of interest is the fetal thyroid hormone status during pregnancy, especially in 
the event of impaired maternal and/or fetal thyroid function or iodine deficiency. 
However, much less is known about the effects of pregnancy on thyroid hormone 
and iodide metabolism in the mother during a normal, hypothyroid or iodine-deficient 
situation. This information is very important, because these conditions might restrict 
the availability of maternal thyroid hormone for the fetuses. 
The aim of this study was to provide insight into maternal thyroid hormone metabo-
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I ism, iodide metabolism and peripheral T3 production at the end of pregnancy. For 
this purpose pregnant rats were studied on day 20 of gestation. 
Thyroid hormone production, metabolism and distribution were evaluated in the 
normal pregnant near-term rat (chapter 2). To study T4 and T3 kinetics nonpregnant 
and near-term pregnant rats were given a bolus injection of [125I]T4 and [131I]T3. The 
physiological parameters were estimated by means of the three-compartment model 
of JJ. DiStefano(10,11). 
In chapter 3, the effects of pregnancy on thyroid hormone concentrations and local 
conversion of JA to T3 in many maternal organs are described. For this purpose a 
steady-state experiment was performed (13, 14, 57-59). 
In chapter 4 the uptake of iodide by the thyroid gland in nonpregnant and near-term 
pregnant rats is compared. The uptake of iodide by the fetal thyroid gland was also 
estimated. Furthermore, the effects of marginal iodine deficiency on thyroidal iodide 
uptake were studied; what are the consequences for the availability of iodide for the 
fetal thyroid ? We chose to induce an iodine deficiency which is only marginal, 
because this situation closely reflects the iodine status in large populations in the 
world. 
The effects of marginal iodine deficiency (chapter 5), and different levels of maternal 
hypothyroidism (chapter 6) on maternal thyroid hormone production, metabolism and 
distribution were evaluated by means of a kinetic study. Special point of interest in 
these studies was the availability of maternal thyroid hormones for the fetuses. 
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THYROXINE AND a.S.S'-TRIIODOTHYRONINE PRODUCTION, META-
BOLISM, AND DISTRIBUTION IN PREGNANT RAT NEAR TERM. 
P.M. Versloot, J. Gerritsen, L. Boogerd, J.P. Schröder-van der Eist, 
and D. van der Heide. 
Am. J. Physiol. 267 (Endocrinol. Metab. 30): E860-E867, 1994. 
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ABSTRACT 
In the pregnant rat near term thyroxine (T4) and 3,5,3'-tri-iodothyronine ( T3) concen-
trations are lower in plasma and extrathyroidal tissues, except T3 in the brain. To 
study the changes in T4 and T3 kinetics a bolus injection of [125I]T4 and [131I]T3 was 
administered to nonpregnant controls and rats 14 and 19 days pregnant. Physiolo-
gical parameters of the production, interpool transport, distribution, and metabolism 
of T4 and T3 were estimated by means of a three-compartment model. The producti-
on and partition of T4 remained unchanged during pregnancy. The total distribution 
volume of T4 was enlarged. On day 19 the plasma clearance rate was doubled, and 
transport to the fast pool was more than tripled. The rate of production of T3 was 
slightly diminished. The plasma clearance rate was increased, but no changes were 
found in the interpool transport rates. These results suggest that in the pregnant rat 
near term the increased transport of T4 is responsible for the distribution of the 
available T4 between the maternal and the fetal compartment. 
Keywords: thyroid hormone, kinetics, deiodinases, pregnancy. 
INTRODUCTION 
Thyroid hormones are of great importance for fetal and postnatal development, 
especially of the central nervous system. A deficiency of thyroid hormone during 
fetal development caused by maternal hypothyroidism in early gestation results in 
damage to the central nervous system (19, 23). 
Convincing evidence has been presented that in humans substantial amounts of 
thyroxine (T4) are transferred from mother to fetus. This results in normal fetal deve-
lopment, even in the case of congenital hypothyroidism. In such a case severe 
neurological damage can be prevented by initiating thyroid hormone treatment within 
a few days of birth (19, 29). 
In humans normal pregnancy is accompanied by a rise in the serum levels of total T4 
and 3,5,3'-triiodothyronine (T3). However, by a rise in the T4-binding globulin the free 
T4 and T3 levels decrease during pregnancy (11). In contrast to the findings for 
humans, plasma T4 and T3 concentrations in the rat are decreased. This leads to 
reduced concentrations of T4 and T3 in the tissues, except T3 in the brain. Mainten-
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ance of the T3 level in the brain can be attributed to increased local production of T3 
from T4 via increased type II deiodinase activity in the brain (2, 21). Despite the con-
siderable decrease in T4 and T3> plasma thyroid-stimulating hormone (TSH) remains 
unchanged or is only slightly increased during pregnancy (2, 8, 13). 
Thyroid hormones are already present in the rat fetus before its own thyroid starts to 
function between days 17 and 18 of gestation (21). Maternal T4 and T3 are transfer-
red to the fetus, as shown in experiments in which the fetal thyroid is impaired. 
However, only T4 can mitigate T3 deficiency in the fetal brain (20). In normal preg-
nant rats T4, but not T3, is transported to the fetuses at the end of gestation (6, 7). 
Information about secretion, distribution, and metabolism of T3 and T4 during preg-
nancy is lacking; nor is it known what the consequences of the lowering plasma 
thyroid hormone levels during pregnancy are for the partition of T4 and T3 over the 
tissues. This information may be obtained from kinetic studies based on the three-
compartment model of distribution and metabolism developed by DiStefano ( 3, 4). In 
this model three compartments can be distinguished: (1) the plasma; (2) tissues that 
exchange T4 and T3 with plasma at a fast rate, the fast pool; and (3) the slow ex-
changing pool, the slow pool. Liver and kidney are considered as the main compon-
ents of the fast pool, while skin, muscles and brain belong to the slow pool (3, 4). 
With this model it should be possible to distinguish and measure the transport of 
thyroid hormones to the fetal pool. 
To investigate whether the decreased T4 and T3 levels in the pregnant rat lead to 
alterations in the biological end-points of thyroid hormone activity we determined the 
activity of a-glycerophosphate dehydrogenase (a-GPD; EC 1.1.2.1) in the liver. We 
have also measured hepatic type I deiodinase (ID-I) and cerebral type II and III 
deiodinases (ID-II and ID-Ill). 
MATERIAL AND METHODS 
Animals 
Three-month-old female Wistar rats (CPB/WU, IFFA CREDO, Brussels) were used. 
At the start of the experiment the rats weighed 213 ± 9 g. The rats were individually 
housed at 22 *C, with alternating 14-h light and 10-h dark periods. The animals were 
fed a semisynthetic American Institute of Nutrition diet (1). The dry food was mixed 
with distilled water (60 % dry weight, 40 % water) containing 10 mg/l potassium iod-
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ide to prevent utilization of labeled iodide by the thyroid (5). This dose of potassium 
iodide does not influence the T4 and T3 production rates (25, 26). 
After two regular estrus cycles the rats were mated. The day that sperm appeared in 
the vaginal smear was taken as day 0 of gestation (21 ). The gestational period of the 
rat is 22 days. 
Design of the study 
Two kinetic experiments were performed with three groups of rats; nonpregnant 
controls, pregnant rats on day 14 and pregnant rats on day 19. In the first experi-
ment the rats received only [125IT4 (n=6, n=A, n=5 respectively), while in an second 
experiment the rats received [125I]T4 and [131I]T3 (n=6, n=6, n=5 respectively). 
In a separate experiment we determined the activity of a-GPD and the deiodinases 
ID-I, ID-II, and ID-Ill in liver and brain of nonpregnant controls (n=7), 14-day preg-
nant rats (n=6), and 19-day pregnant rats (n=6). 
Kinetic and analytical protocols 
The rats received, via a cannula inserted into the right jugular vein (24), a 400 pi 
bolus injection of a solution containing 10 uCi [12SI]T4 and 10 uCi [131I]T3 in saline 
containing heparin (0.3 U/ml; Organon, Tilburg, The Netherlands), ticarcillin (0.4 
mg/ml; Ticarpen, Beecham S.A., Heppignies, Belgium) and 5% normal rat serum. 
Ticarcillin is used in the solutions containing labelled iodothyronines to prevent 
eventual bacterial infection and diminish artifactual deiodination. It has been used 
for that reason since described by Van Doorn (5). 
Blood samples of 0.2 ml were taken at 1, 4.5, 10, 23, 44, 115, 202 and 315 min; 0.4 
ml were drawn at 465, 600, 900, 1200 and 1440 min, as given by the optimal time 
schedule according to DiStefano et al. (3,4). 
Plasma (50-100 pi in duplicate) was used for counting the total 131l and 125l activities. 
The plasma samples were extracted with ethanol/ammonia (25 %)( 197:3 v/v) with 
0.1 mM propylthiouracil (PTU). The dried extracts were dissolved in 0.1 ml 0.2 M 
ammonia containing carrier T4, T3 and potassium iodide (1 mg/10 ml) and subjected 
to high-performance liquid chromatography (HPLC) to separate the iodothyronines, 
according to the method described by Schröder-van der Eist and van der Heide (25). 
Plasma volume in controls and pregnant rats was determined in another experiment. 
Rat serum albumin (Nordic Immunological Laboratories, Tilburg, The Netherlands) 
was labelled with 125l by the lactoperoxidase method and biologically screened (17). 
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A small amount of the 125l-labelled albumin was injected via the cannula. At 1, 3, 5, 
10, 15, 20 and 30 minutes blood samples were taken. The radioactivity in the plasma 
was counted, and the percentage dose per milliliter was calculated. The data were 
fitted to a single exponential function. The extrapolated activity at t(0) was used to 
determine the plasma volume [100/t(0)] (3). 
The endogenous concentrations of T4 and T3 in plasma were measured by rat radio-
immunoassay (RIA) in samples taken before the kinetic ex-periment was performed. 
Plasma TSH was measured by the specific RIA developed for the rat by the National 
Institute of Diabetes and Digestive and Kidney Diseases of the National Institute of 
Health (USA). Reference preparation RP-2 was used as a standard. 
The percentage doses of [131I]T3 and [125I]T4 per milliliter plasma were calculated from 
Calculations 
[ 31l]~i  
the total radioactivities and the [131I]T3 and [i25l]T4 distributions on the HPLC chro-
matogram. 
These percentage doses per milliliter, together with the plasma volume at t(0), were 
individually fitted to sums of n=1 to 3 exponentials 
Y(t)= A, exp(Vt) + A2 exp(A2*t) + A3exp(A3*t) 
using the program DIMSUM, in which coefficients Aj are expressed in percentage 
dose per ml and exponents Aj are expressed per min (16). 
To calculate 24 parameters of production, distribution and metabolism the program 
MAMPOOL (15) was used. The sum of the three exponential functions was fitted (by 
weighted least-squares regression) to the data collected for each rat individually 
and, together with plasma T4 and T3 levels, substituted in the three-compartment 
model, according to the kinetic T4 and T3 studies of DiStefano et al. (3, 4). 
The calculated parameters are summarized in table 1. 
All data are expressed as mean ± SE. Data were analyzed using the Statistical 
Package for Social Sciences (SPSS)(28). All data were subjected to one-way ana-
lysis of variance, and statistical differences among the groups were determined 
using the modified least significant difference method. 
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Table 1 : Nomenclature for kinetic parameters of T4 and T3. 
T>PR 
T3-PR 
T3-PAR 
PCR 
TRS 
DRFOI DRgo 
Q,, Q2and Q3 
VP,V2, V3 and VD 
% PF and % PS 
Transit time 
Total residence time 
Rate of thyroidal production of T4; pmol/h 
Rate of total body production of T3; pmol/h 
Rate of plasma appearance of T3; pmol/h 
Plasma clearance rate; ml/h 
Interpool transport rates between plasma and the fast 
and the slow pool, respectively in each direction; 
pmol/h 
Irreversible rate of disappearance from the fast and 
slow tissue pools, respectively; pmol/h 
Sizes of the plasma, fast and slow pools, respectively; 
pmol 
Plasma equivalent distribution volume of he plasma, 
fast, slow and total body pools, respectively; ml 
Fraction of T4 or T3 in plasma transported unidirectio-
nally to the fast and slow tissue pools, respectively 
Single mean transit time for T4 and T3 molecules tra-
versing plasma and the fast and slow pools; min 
All-pass mean residence time in the entiresystem; min 
Enzyme and protein determinations 
Liver mitochondrial a-GPD was measured by means of the method described by 
Garrib and McMurray (10). 
The determinations of ID-I, ID-II, and ID-Ill activities were performed by the method 
as described by Janssen et al. (12). In short, ID-I activity was determined in liver 
homogenates. The final assay conditions were: 1 uM reverseT3 (rT3) and [12Sl]rT3, 0.1 
M phosphate (pH 7.2), 2 mM EDTA and 5 mM dithiothrietol (DTT). Incubation time 
was 30 min at 37 °C. ID-II activity was determined by incubation of 0.5 nM [125I]T4 for 
1 h at 37 °C with brain homogenate in the presence of 1 uM T3, 1 mM PTU, 25 mM 
DTT, 0.1 M phosphate (pH 7.2) and 2 mM EDTA. ID-Ill activity in brain homogenates 
was determined by incubating 3,5-[125l]T3 for 1 h at 37 °C in the presence of 1 uM 
rT3, 0.1 mM PTU, 50 mM DTT, 0.1 M phosphate (pH 7.2) and 2 mM EDTA. 
All deiodinase reactions were stopped by adding 100 pi pooled human serum and 
500 pi ice-cold trichloroacetic acid. Released 1 2 5 l ' was separated from protein-bound 
iodothyronines by centrifugation and counted. 
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Protein was determined by the bicinchoninic acid method (Pierce) using bovine 
serum albumin as standard. 
RESULTS 
During pregnancy we found a significant decrease in the plasma concentrations of 
T4 and T3. The TSH concentration did not change significantly (Table 2). 
Table 2: Body weight and plasma thyroid hormone concentrations in nonpregnant controls 
and 14 and 19-day pregnant rats. 
BW, g 
T4, nM 
T3 ,nM 
TSH, ng/ml 
Controls 
211 ±3 
33.8 ±2.2 
1.05 ±0.07 
0.29 ± 0.05 
Pregnant 
day 14 
274 ± 5' 
27.1 ±1.6 
0.61 ± 0.07* 
0.33 ± 0.06 
Pregnant 
day 19 
315 ±6* e 
23.3 ± 1.8e 
0.57 ± 0.09e 
0.57 ± 0.05 
Values are means ± SE. Groups are, respectively, n=12; n=10 and n=10, except for T3 (n=6; 
n=6; n=5). BW, body weight; TSH, thyroid-stimulating hormone. Statistical significance, 
P < 0.05: * day 14 vs. controls; e day 19 vs. controls; * day 19 vs. day 14. 
TA kinetics 
For the T4 kinetics animals from the two experiments were taken together. No signifi-
cant differences in T4 kinetics was found between the animals which received only 
[125I]T4, and those receiving [125I]T4 and [131I]T3. 
Table 3 shows the mean values of the A and A values and the fractional turnover and 
transport rates (k11: k^, k^, k12k21, k13k31). The disappearance curves for T4 from the 
plasma, based on the mean A and h values for the three groups, are shown in Fig. 1. 
The absolute magnitude of the slopes of the regression lines describing the 
disappearance of T4 from each of the three pools were significantly increased. This 
could imply that T4 disappeared more quickly from all three pools in the pregnant rat. 
The mean results of distribution volumes, pool sizes and transport rates of T4 are 
summarized in Table 4. The data are expressed per 100 g body wt and per total 
animal (maternal + fetal compartment). Table 5 shows the transit times of T4 in the 
three pools and the mean residence time in the body. 
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Table 3: T4 kinetic model parameters: controls and pregnant rats. 
A, (% dose/ml) 
X, (1/min) 
A2 (%dose/ml) 
A2 (1/min) 
A3(%dose/ml) 
A3 (1/min) 
k^ (1/min) 
k^ (1/min) 
k33 (1/min) 
k12k21 (1/min2) 
k13k31 (1/min2) 
Values are means ± SE 
Controls 
(n=12) 
Pregnant 
Day 14 
(n=10) 
Coefficients and exponents 
4.87 ±0.15 
-0.22 ± 0.03 
2.39 ±0.18 
-0.017 ±0.002 
2.46 ± 0.07 
-0.0013 ± 0.0001 
3.59 ±0.15* 
-0.47 ±0.12 
1.84 ±0.18 
-0.022 ± 0.005 
1.92 ±0.13 
-0.0012 ±0.0001 
Fractional turnover and transport 
-0.117 ±0.0012 
-0.118 ±0.013 
-0.009 ± 0.001 
0.013 ±0.003 
0.00013 ±0.0000 
-0.232 ± 0.054 
-0.251 ± 0.061 
-0.012 ±0.003 
0.083 ± 0.039 
0.00037 ± 0.0002 
Statistical significance, P< 0.05: day 14 vs 
Pregnant 
Day 19 
(/7=10) 
2.81 ±0.15®* 
-0.83 ±0.10®* 
1.94 ±0.09 
-0.030 ± 0.004 
1.71 ± 0.10e 
-0.0016 ± 0.0001e* 
rates 
-0.368 ± 0.042 e 
-0.482 ± 0.056 e 
-0.015 ±0.002 
0.183 ± 0.035 e 
0.00041 ± 0.0001 
controls; e day 19 vs. 
controls; * day 19 vs. day 14. 
Table 5: Transit times and total residence time for T, 
Transit time, min 
Plasma 
Fast pool 
Slow pool 
Total residence time, min 
Controls 
(n=12) 
9.5 ±0.8 
9.7 ±1.1 
127 ±15 
790 ± 30 
Pregnant 
Day 14 
(n=10) 
6.2 ±1.0 
6.4 ±1.3 
124 ±25 
796 ±64 
Pregnant 
Day 19 
(n=10) 
3.4 ± 0.8e 
2.8 ± 0.8® 
96 ±32 
631 ± 22e* 
Values are means ± SE. Statistical significance, P<0.05: day 14 vs. controls; ® day 19 vs. 
controls; *day 19 vs. day 14. 
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Figure 1: T4-disappearance curves for con-
trols and 14 and 19-day pregnant rats ob-
tained with a three exponential model. 
Panel A: plot of log y(t) (in % dose/ml) 
against time, with the least squares regres-
sion line on the final straight part of the 
curve, giving estimates of coefficient A3 
and exponent A3. 
Panel B: plot of log [y(t) - A3 exp(A3*t)] 
against time, with the least squares regres-
sion line on the curve, giving estimates of 
coefficient A2 and exponent A2. 
Panel C: plot of log [y(t) - A3 exp(A3*t) - A2 
exp(A2*t)] against time, giving estimates of 
coefficient A, and exponent A,. 
time (min) 
~*~ eontr. -*- day - • - day 
14 19 
n=12 n=10 n=10 
The T4 models for controls and 19-day pregnant rats are given in Fig. 2. For almost 
all parameters the value on day 14 of gestation was somewhere between the value 
for the controls and that for 19-day pregnant rats. 
The serum T4 concentration decreased from 33.8 nM to 23.3 nM on day 19 of gesta-
tion. The production of T4 by the thyroid did not change significantly during preg-
nancy. The total amount of T4 remained unchanged, as did the absolute mass of T4 
in the three pools. During pregnancy, the distribution volume of T4 increased. The 
sizes of the plasma and slow pools increased by 50%, whereas the fast pool was 
only 25% larger. 
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A. 
BW = 211 gr. 
T4 = 33.8 nM 
100 
BW = 315 gr. 
T4 = 23.3 nM 
• TR = pmol/h. 
PCR = 2.91 ml/h 
tot. time = 789 min. 
118 
59 
• TR = pmol/h. 
PCR = 5.10 ml/h 
tot. time = 631 min. 
Figure 2: Mean 3-pool model of T4 kinetics in nonpregnant controls (A) and 19-day pregnant 
rats (B). See table 1 for nomenclature. 
Many alterations in the transport of T4 occurred. On day 19 of gestation the plasma 
clearance rate (PCR) for T4 had increased nearly twofold. The transport to the fast 
pool and vice versa was more than tripled, and transport to the slow pool and back 
was almost doubled. The total residence time of T4 decreased from 789 to 631 min. 
We found a reduction in the transit time in plasma and the fast pool to 30% of the 
control value. The transit time in the slow pool was 50% lower. 
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73 kinetics 
A complete overview of the kinetic data and statistics of T3 is given in Tables 6-8. 
The T3 models for controls and 19-day pregnant rats are given in Fig. 3. 
The plasma T3 concentration markedly decreased during pregnancy. Although all A 
and Â values on day 19 of gestation were significantly different from controls, only a 
few changes in the physiological parameters were found. 
Table 6: T3 kinetic model parameters: controls and pregnant rats. 
A, (% dose/ml) 
A, (1/min) 
A2 (%dose/ml) 
k2 (1/min) 
A3(%dose/ml) 
A3 (1/min) 
k^ (1/min) 
k22 (1/min) 
k33 (1/min) 
k12k21 (1/min2) 
k13k31 (1/min2) 
Controls 
(n=6) 
8.89 ± 0.31 
-1.66 ±0.03 
0.79 ± 0.06 
-0.048 ± 0.004 
0.212 ±0.018 
-0.0020 ± 0.0003 
Pregnant 
Day 14 
(17=6) 
Pregnant 
Day 19 
(n=5) 
Coefficients and exponents 
6.63 ± 0.39 
-1.71 ±0.15 
0.68 ± 0.03 
-0.052 ± 0.005 
0.195 ±0.14 
-0.0022 ± 0.0002 
5.88 ±0.13® 
-1.89 ±0.09 
0.62 ± 0.08 
-0.041 ± 0.007 
0.173 ±0.014 
-0.0023 ± 0.0003 
Fractional turnover and transport rates 
-1.431 ±0.07 
-0.206 ± 0.016 
-0.0093 ± 0.002 
0.239 ± 0.020 
0.0026 ± 0.0005 
-1.514 ±0.14 
-0.237 ± 0.020 
-0.0116 ±0.001 
0.293 ± 0.005 
0.0030 ± 0.0004 
-1.620 ±0.13 
-0.247 ± 0.030 
-0.0096 ± 0.001 
0.344 ± 0.057 
0.0017 ±0.0004 
Values are means ± SE. Statistical significance, P< 0.05: day 14 vs. controls; e day 19 vs. 
controls. 
The plasma appearance rate and the production rate for T3 were diminished when 
expressed per 100 g body wt, but no significant change, due to a large variation, was 
found per total body weight. During pregnancy the distribution volume of the plasma 
and the two tissue pools was enlarged. The amount of T3 in the plasma and the fast 
pool had not changed, whereas the T3 in the slow pool exhibited a sharp decrease. 
PCR increased. No significant differences were found in the transport rates, transit 
times, and total residence time for T3. 
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A. 
BW = 211 g. 
T3 = 1.05 nM 
• TR = pmol/h. 
PCR = 45.4 ml/h 
tot. time = 607 min. 
B. 
BW = 211 g. 
T3 = 0.57 nM 
• TR = pmol/h. 
PCR = 64.4 ml/h 
tot. time = 490 min. 
Figure 3: Mean 3-pool model of T3 kinetics in nonpregnant controls (A) and 19-day pregnant 
rats (B). See table 1 for nomenclature. 
Enzyme activities 
The changes in the a-GPD activity in the liver are shown in Fig. 4. When expressed 
per milligram of protein there is a significant decrease in the a-GPD activity, but no 
change in activity is found when calculated per total liver. 
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Table 8: Transit times and total residence time for X,. 
Controls 
(n=8) 
Pregnant 
Day 14 
(n=6) 
Pregnant 
Day 19 
(n=5) 
Transit time, min 
Plasma 0.67 ± 0.02 
Fast pool 4.99 ± 0.36 
Slow pool 114 ±15 
Total residence time, min 607 ± 76 
Values are means ± SE. 
0.69 ± 0.07 
4.38 ± 0.39 
94 ±14 
507 ± 48 
0.63 ± 0.05 
4.30 ± 0.56 
109 ±9 
490 ± 33 
300
 r 
200 
100 
0 
per mg protein 
mOD/min/mg protein 
per total liver 
mOD/min (thousands) 
Figure 4: ^glycerophosphate dehydrogenase activity (per mg protein and per total liver) in 
liver homogenates from controls (solid bars; n=7) and 14- (gray bars; n=6) and 19-day (hat-
ched bars; n=6) pregnant rats. Values are means ± SE. ' P < 0.05. 
Figure 5 shows the changes in deiodinase activities during pregnancy. Hepatic ID-I 
increased from 213 pmol/min/mg protein for controls to 270 pmol/min/mg protein on 
day 19 of gestation. In the pregnant rat near term the weight of the liver increased by 
> 50%. The protein concentrations in the subcellular fractions were unchanged, 
reuslting in a relatively larger increase in the ID-I activity when calculated for the 
total liver. Brain ID-II had not changed on day 14 but was markedly increased on day 
19 of gestation. The activity of ID-Ill in the brain remained unchanged during preg-
nancy. The brain weight was not significantly different in the pregnant rats. 
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5.04 
hepatic ID-I brain ID-II brain ID-Ill 
pmol/min/mg protein fmol/hr/mg protein fmol/min/mg protein 
Figure 5: Deiodinase activities in total homogenates from liver (ID-I) and brain (ID-II and ID-Ill) 
from controls (solid bars; n=7) and 14- (gray bars; n=6) and 19-day (hatched bars; n=6) 
pregnant rats. Values are means ± SE. * P < 0.05. 
DISCUSSION 
In this study kinetic experiments were performed to investigate the mechanisms of 
the changes in thyroid hormone concentrations in the pregnant rat near term. 
The kinetic parameters of thyroid hormone production, distribution, and metabolism 
are expressed per total animal (maternal + fetal compartment) and per 100 g body 
wt, because of the enormous gain in body weight due to the fetal compartment. After 
delivery bodyweight of the dams is nearly the same as that of age-matched nonpreg-
nant controls; no essential alterations in bodyweight of the dams takes place during 
pregnancy. The volume of distribution of each pool increases proportionately to the 
increase in body weight. This would mean that the partition of T4 in plasma and fast 
and slow pool is the same in pregnant and nonpregnant rats. When no changes are 
found in the proportion of T4 in the three pools of the maternal compartment, this in-
dicates that the developing placental and fetal compartments are made up of plasma 
and fast and slow pools similar to those of the mother. 
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Production of T4 and T3 
Under normal conditions a lower plasma T4 concentration will lead, by means of 
stimulation of TSH release, to an increase in the T4 production rate. However, the 
free fraction of T4 is increased in the pregnant rat, resulting in unchanged free T4 
plasma concentrations (9). This could explain the unchanged TSH levels. 
Our experiment shows that there is no increase in thyroidal T4 production. Others 
found an increased production of T4 (7), probably because they used a noncompart-
mentalized method. The total amount of T4 in the three pools remains unaltered; the 
reduced T4 concentration in plasma and tissues (2) in the pregnant rat could be due 
to the enhanced distribution volume. 
The total body production rate of T3 was unchanged. However, the T3 production rate 
has not increased proportionately to the increase in body weight, leading to a de-
creased T3 production rate per 100 g body wt. This can be explained by a reduced 
thyroidal T3 production and/or a decreased peripheral production from T4. However, 
thyroidal T4 production does not change essentially, and one would not expect the 
thyroidal production of T3 to be specifically lowered. On the basis of the decreased 
plasma T4 and T3 levels, one would expect that the pregnant rat near term is hypo-
thyroid. Just as in hypothyroid rats (14, 27) we found an increase in cerebral ID-II 
activity leading to normal tissue T3 levels (2). However, instead of the decrease 
found in hypothyroid rats (14, 26), ID-I is also increased in livers of pregnant rats. 
This finding is supported by Calvo et al.(2). In contrast, no significant differences in 
hepatic and renal T3 generation from T4 have been observed by others (9, 30). From 
the increased in vitro ID-I and ID-II activities it could be expected that the production 
of T3 from T4 was increased. However, from the kinetic data this appears not to be 
the case. A possible explanation for this can be found in the rT3. 
The rT3 level in plasma of pregnant rats is lower than in nonpregnant rats (2), des-
pite the increased placental ID-Ill activity. However, the molar ratio of rT3 to T4 is 
doubled in the pregnant rat (2). This can result in a decreased in vivo T3 production, 
since rT3 is the preferred substrate for ID-I, whereas the in vitro activity of ID-I is 
increased. 
Transport of 7"4 and T3 
The T4 PCR is markedly increased. Others (9) have suggested that the increased 
PCR is due not only to enhanced deiodination but also to the marked increase in the 
clearance of T4 from plasma via the gastrointestinal pathway in the pregnant rat. 
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However, we did not find any significant changes in the disposal of T4 from the body. 
We think that the major cause of the elevated PCR for T4 is the result of the en-
larged volumes of plasma and the slow pool. 
This is also the case for the PCR for T3; both the PCR and the plasma volume are 
increased by 50%. From our study it is clear that gestation is associated with signi-
ficantly higher fractional T4 turnover rates for different tissue pools. This results in 
enhanced transport rates for T4 during pregnancy, especially for transport to the fast 
pool. It is unlikely that the increase in transport rate can be attributed only to the liver 
and kidney, which are considered to be the main organs of the fast pool. 
Calvo et al. found that total liver and kidney from 21 day pregnant rats contain 35% 
less T4 than those from the nonpregnant rat (2). In our model the total amount of T4 
in the fast pool remained unchanged. We suggest that an explanation for this discre-
pancy could be that in the pregnant rat the fast pool consists not only of the liver and 
kidney but also of a new, rapidly developed compartment (placentas plus fe- tuses). 
It is possible that this placentofetal compartment represents even "faster" thyroid 
hormone metabolism, but we were not able to distinguish a fourth exponent, located 
mathematically between plasma and the fast pool, on our disappearance curve. 
In the three-compartment model the sum of the disposal rates equals the production 
rate in all cases. The individual values for the irreversible disposal rates from the 
slow and the fast pool (DR^ and DRfc, respectively) are rough estimates, which can 
vary in theory between zero and the production rate. DiStefano et al. (3) have made 
the assumption that the DR^ and DRR, are both half the production rate. However, 
we think that the disappearance rate from the fast pool is larger than from the slow 
pool. We based this on the threefold increased transport rate from plasma to fast 
pool and the unaltered transport to the slow pool. This could mean that the disposal 
from the slow pool is the same in the nonpregnant and the near term pregnant rat. 
For that reason we assume that the disposal from the fast pool is increased with at 
least 18 pmol/h (DRTO=50; DRfo=68 on day 19). We speculate that when the disposal 
from liver and kidney remained unaltered in the pregnant rat, this 18 pmol/h disap-
pears from the placental and fetal compartments. 
The parameters of T3 transport in pregnant rats were not significantly different from 
those found for nonpregnant rats. This is in accordance with the results of Dubois et 
al. (6), who showed that T3 is not transported across the placenta. 
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Thyroid hormone actions 
Hepatic a-GPD activity per milligram protein is decreased in the pregnant rat (2, 19). 
This is in agreement with the lowered T4 and T3 concentrations in the liver. However, 
only when expressed per total liver can the actual enzyme activities of controls and 
pregnant rats be compared. This total a-GPD activity remained unchanged. 
In summary, in the pregnant rat near term available T4 is distributed between the 
maternal and the fetal compartment by very fast transport, presumably to the pla-
centa and fetuses. The unchanged T3 kinetics are in agreement with the absence of 
placental transfer of T3 in the normal pregnant rat at the end of gestation. The preg-
nant rat does not produce more thyroid hormones to compensate for loss to the fe-
tuses. 
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CHAPTER 3 
CONTRIBUTION OF T3 PRODUCED LOCALLY FROM T4 IN SEVERAL 
MATERNAL TISSUES OF THE NEAR-TERM PREGNANT RAT. 
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ABSTRACT 
3,5,3'-Triodothyronine (T3) is produced by the thyroid and locally, by monodeiodina-
tion of thyroxine (T4), in the peripheral tissues. During pregnancy the thyroid hor-
mone status in rats is altered: plasma and tissue levels of T4 and T3 are decreased. 
We investigated the effects of pregnancy on the contribution of T3 produced locally 
in the maternal tissues by administering a continuous infusion of [125I]T4 and [131I]T3. 
The transport of T4 to almost all maternal organs diminished. Less T3 was trans-
ported from the plasma to brown adipose tissue (BAT), liver, kidney and pituitary. In 
BAT and brain the amount of locally produced T3 decreased, despite the increase in 
deiodinase type II activity in the brain. In liver the contribution of locally produced T3 
remained constant, despite an increase in deiodinase type I activity during preg-
nancy. This discrepancy between deiodinase activities and locally produced T3 can 
be explained by an insufficient availability of T4. The decreased maternal T4 concen-
tration, together with the transport of T4 to the feto-placental compartment, results 
indirectly in a diminished availability of T3 in the maternal organs. 
INTRODUCTION 
During pregnancy maternal thyroid hormones are exceedingly important for normal 
development of the fetal central nervous system (7). The biologically active form of 
thyroid hormone is 3,5,3'-triiodothyronine (T3) (13). T3 is produced not only by the 
thyroid but also locally in peripheral tissues by monodeiodination of thyroxine (T4). In 
liver, kidney and the thyroid monodeiodination of T4 is catalyzed by the deiodinase 
type I enzyme (ID-I), while in the pituitary, central nervous system and brown adip-
ose tissue (BAT) deiodinase type II enzyme (ID-II) is responsible for the conversion 
ofT4toT3(10). 
Some tissues can adapt to alterations in plasma thyroid hormone status, and regu-
late intracellular T3 by changing the deiodinase enzyme activities, and thus the 
amount of locally derived T3. During hypothyroidism a decrease in hepatic ID-I 
activity, and an increase in brain ID-II activity have been described (9, 18). This is in 
agreement with the contribution of the local conversion found in those organs; in 
liver and kidney local conversion is decreased, whereas in brain an increase has 
been found (4). 
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Especially in the central nervous system local conversion of T4 is the main source of 
intracellular T3. Therefore, when the amount of T3 available from plasma is de-
creased, this can be compensated by an increase in the local conversion of T4 to 
some extent (4). 
In the near-term pregnant rat this condition is associated with decreased T4 and T3 
levels in plasma and tissues (2, 12, 20). From earlier studies of T4 and T3 kinetics it 
has been suggested that in the near-term pregnant rat T4 is transported from the 
plasma to the feto-placental compartment at a very fast rate (20). This leads to a 
decrease in the availability of T4 for the maternal tissues. No changes were found in 
the transport of T3. 
Studies by the Madrid group have shown that T4 and T3 concentrations in maternal 
tissues are decreased at the end of gestation (2, 12). However, it is not known how 
pregnancy influences the amount of T3 produced locally in several tissues. An 
indication about T3 produced locally in several tissues is only based on measure-
ments of deiodinase activities. It has been found that in the near-term pregnant rat 
hepatic ID-I as well as brain ID-II activity is increased (2, 20). The aim of this study 
was to compare the contribution of T3 produced locally in maternal tissues of the 
non-pregnant and near-term pregnant rat. By administering a continuous simultan-
eous infusion of [12SI]T4 and [131I]T3 (4, 5, 16, 17), T4 and T3 concentrations in mater-
nal tissues, the relative contribution of plasma-derived vs. locally produced T3, 
thyroidal T4 and T3 secretion, and the plasma-to-tissue ratios of T4 and T3 were 
determined. 
MATERIAL AND METHODS 
Animals 
Three-month-old female Wistar rats (CPB/WU, Iffa Credo, Brussels) were used. The 
rats were individually housed in metabolic cages at 22 °C, with alternating 14-h light 
and 10-h dark periods. The animals were fed a semisynthetic American Institute of 
Nutrition diet (1 ). The dry food was mixed with distilled water (60% dry weight, 40% 
water) containing 10 mg/l potassium iodide. 
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Design of the study 
Two groups of rats were used in this study, i.e. nonpregnant and pregnant rats. After 
two regular estrus cycles the rats were mated . The day that sperm appeared in the 
vaginal smear was taken as day 0 of gestation. At the start of the infusion the rats 
weighed 211±4 g (controls) and 237±3 g (pregnant, day 8). 
The continuous intravenous infusion of [125I]T4 (30 uCi/rat/day) was started on day 8 
of pregnancy; 4 days later [131I]T3 was added to the infusion fluid. The labeled iodo-
thyronines were administrated at a constant rate (10 ml/day), via a cannula which 
was inserted into the right jugular vein, and extended to the right atrium (14) at least 
4 days before the continuous infusion was started. The rats were unrestrained, and 
could eat and drink normally. 
Urine and feces were collected from the start of infusion. The 125l and 131l contents 
were counted and expressed as a percentage of the daily infused radioactivity. The 
animals were in isotopic equilibrium when the sum of radioactivity in urine and feces 
was equal to the daily administered dose. 
Labelled iodothyronines 
High specific activity [125I]T4 and [131I]T3 (specific activity ~ 2200 and ~ 3500 uCi/ug, 
respectively) were prepared in our laboratory (8, 21). Na125l and Na131l were pur-
chased from Amersham (Aylesbury, UK); L-T3 and 3,5-L-diiodothyronine, the re-
spective substrates for labelling, were obtained from Sigma (St. Louis, MO). Purity of 
the tracers was assessed by means of high performance liquid chromatography 
(HPLC). All infusions consisted of a sterile 0.9 % NaCI solution containing 0.2 mg/ml 
ticarcillin (Ticarpen; Beecham, Heppignies, Belgium) and 0.3 U/ml heparin (Orga-
non, OTilburg, The Netherlands). The stock infusion solutions were stored at 4 °C in 
the dark. The infusion flasks were protected from light to minimize artifactual de-
iodination of the tracers 
Analytical procedures 
At the end of the infusion period, i.e. day 20 of gestation for the pregnant rats, the 
rats were bled under light ether anesthesia. Blood was collected in heparinized 
tubes. To prevent artifactual deiodination propylthiouracil (PTU) was added to a final 
concentration of 0.1 mM (11). To free the tissues of trapped blood, the rats were 
perfused with 40-50 ml of a 0.9 % NaCI solution containing 3 U heparin/ml and 0.1 
mM PTU; outflow was obtained by puncturing the inferior vena cava. Maternal 
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tissues were then immediately excised and kept on ice. Either whole small organs or 
weighed portions of the bigger organs were minced and homogenized in a Potter 
homogenizer (B. Braun, Melsungen, Germany) at 0 °C in methanol containing 0.1 
mM PTU, carrier T4 and T3 and potassium iodide (1mg/10 ml). The pituitaries were 
homogenized in 1.5 ml saline containing carrier and PTU. 
To determine the iodothyronine concentration a measured aliquot was taken of each 
tissue homogenate and the plasma; the 125l and 131l contents were counted. The 
samples were extracted with methanol-ammonia (25 %, 197:3 vol/vol) with 0.1 mM 
PTU. The dried extracts were dissolved in 0.1 ml 0.2 M ammonia containing carrier 
T4, T3 and potassium iodide (1 mg/10 ml) and subjected to HPLC to separate the 
iodothyronines. The analyses with HPLC were performed according to the method 
described earlier (16). 
After decay (7-8 half lives) of the 131l initially present in the samples the concentra-
tions of stable T4 and T3 in plasma were assessed by a specific radioimmunoassay 
(RIA) for rats using [131I]T4 and [131I]T3 as tracers (6). Plasma TSH was measured by 
the specific RIA developed for the rat by the National Institute of Diabetes and 
Digestive and Kidney Diseases of the National Institutes of Health. Reference pre-
paration RP-2 was used as a standard. 
Calculations 
The levels of T4, T3, tissue T3 derived from T4 (Lc(T3(T4)) and plasma-derived T3 
(P(T3)T3) were calculated (4, 5, 16, 17). 
In short: 
Tissue T4 (pmol/g wet wt) 
tissue [125I]T4 (% dose/g) 
= X plasma T4 (pmol/ml; RIA) 
plasma [125I]T4 (% dose/ml) 
The concentration of [125I]T4 in the tissue was corrected for trapped plasma (5). 
Lc T3(T4) was calculated as follows 
tissue [131I]T3 (% dose/g) 
X plasma [125I]T3 (% dose/ml) 
plasma [131I]T3 (% dose/ml) 
tissue [125I]T3 derived from plasma (% dose/g) 
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Then 
tissue Lc [125I]T3 (% dose/g) 
= total tissue [125I]T3 (% dose/g) 
- tissue [125I]T3 derived from plasma (% dose/g) 
Thus 
tissue Lc T3(T4) (pmol/g) 
tissue Lc [125I]T3 (% dose/g) 
= X plasma T4 (pmol/ml; RIA) 
plasma [125I]T4 (% dose/ml) 
whereby [125I]T4 was multiplied by 2 to correct for the loss of 12SI from the distal 
ring of T4. 
The concentration of T3 derived from plasma in the various tissues was obtained as 
follows 
tissue T3 derived from plasma (pmol/g) 
tissue [131I]T3{% dose/g) 
= X plasma T3 (pmol/ml; RIA) 
plasma [131I]T3 (% dose/ml) 
The total level of T3 in a tissue is the sum of the values calculated for tissue Lc T3(T4) 
and pT3(T3). 
The rate of infusion of [12SI]T4 and [131I]T3 and their respective blood levels were used 
to calculate the plasma clearance rates (PCR) for T4 and T3. If the plasma concentra-
tion is expressed as a percentage of the infused dose (in 1 h/100 g body wt), then 
PCR (ml • h"1 • 100 g body wt"1) 
100 
%dose (h • 100 g body wt'1« ml '1 ) 
The production rate (PR) for T4, or the plasma appearance rate (PAR) for T3, is the 
PCR for T4 or T3 multiplied by their respective plasma concentrations. 
The production of T3 by the thyroid (ThPRT3) can be calculated as follows: 
since the amount of circulating T3 derived from T4 (T3(T4)) is given by 
% dose/ml [125I]T3 
T3(T4) = X plasma T4 (pmol/ml; RIA) 
% dose/ml [125I]T4 
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and T3(T4( (pmol/ml) 
X 100 % = % T3(T4) 
plasma T3 (pmol/ml; RIA) 
then {100-[%T3(T4)]} X PAR T3 = ThPRT3 in picomoles per hour per 100 
grams bodyweight. 
All results are expressed as means ± SE. Data were analyzed using the Statistical 
Package for Social Sciences (19). Statistical analysis was performed by means of 
the Student's f test. 
RESULTS 
Each rat received the continuous infusion until the individual 1 2 5 l - and ^^-radioactivi-
ties in urine and feces equaled the daily input for at least two days. This occurred in 
both groups after 10 days of [125I]T4 infusion and 7 days of [131I]T3 infusion. At this 
time the rats were assumed to be in isotopic equilibrium as far as the major pools of 
T4, T3 and their metabolites were concerned. 
Table 1 : Bodyweight and plasma thyroid hormone concentrations in nonpregnant 
controls and 20-day pregnant rats. 
Bodyweight, g 
# fetuses 
plasma T4, nM 
plasma T3, nM 
plasma TSH, ng/ml 
Controls 
(n=10) 
229 ± 2.7 
30.7 ± 3.2 
0.62 ± 0.04 
0.70 ± 0.04 
Pregnant 
(n=9) 
305 ± 4.8* 
12 ±1 
18.9 ±4.8 
0.52 ± 0.03 
0.80 ±0.11 
Data are expressed as means ± SE. T4l thyroxine; T3, 3,5,3'-triiodothyronine; 
TSH, thyrotropin. P< 0.01: " pregnant vs. controls. 
Table 1 shows that plasma T4 decreased in pregnant rats. Plasma T3 and plasma 
TSH did not change significantly. Plasma clearance rates (PCR) and production 
rates (PR) for T4 and T3 are expressed per total animal and per 100 g body wt (Table 
2). No alterations were found in the PCR for T4 and T3 when expressed per 100 g 
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body wt, however the PCR for T4 increased significantly per total animal. The pro-
duction of T4 remained constant for the total animal. For T3 the PAR decreased per 
100 g body wt but remained constant per total animal. Per total animal the contribu-
tion of T3 produced by the thyroid increased, whereas extrathyroidal T3 production 
showed a decrease. 
Tabel 2: Plasma clearance rates for T4 and T3, production rate for T4, plasma appearance rate 
for T3 and T3 production by the thyroid and local conversion from T4 in nonpregnant controls 
and 20-day pregnant rats. All values are expressed per total animal and per 100 g body wt. 
Per total animal Per 100 g body wt 
Controls Pregnant Controls Pregnant 
(n=10) (n=9) (n=10) (n=9) 
PCR T4, ml/hr 
PCR T3, ml/hr 
PR T4, pmol/hr 
PAR T3, pmol/hr 
ThPR T3, pmol/hr 
T3 (T4), pmol/hr 
2.16 ±0.21 
46.7 ± 3.6 
63.3 ± 6.6 
28.5 ±2.4 
7.5 ±2.3 
21.1 ±2.7 
3.47 ± 0.23* 
51.7 ±2.2 
64.1 ±5.8 
26.5 ±1.3 
13.3 ±1.6* 
13.2 ±0.9* 
0.95 ±0.10 
20.4 ±1.6 
27.7 ±2.9 
12.5 ±1.2 
3.3 ±1.0 
9.2 ±1.2 
1.14 ±0.07 
16.9 ±0.7 
21.0 ±1.8 
8.7 ± 0.4* 
4.3 ±0.5 
4.4 ± 0.3* 
Data are expressed as means ± SE. PCR, plasma clearance rate; PR, production rate; PAR, 
plasma appearance rate; ThPR, production rate of T3 by the thyroid; T3 (T4), production rate of 
T3 from local conversion of T4. P < 0.05: * pregnant vs. controls. 
The total tissue concentrations of T4 and T3 are shown in Fig. 1. In all tissues the T4 
concentration diminished significantly. The total T3 concentration decreased in all 
organs, except the ovary which exhibited an increase. 
Figure 2 shows the contributions of plasma-derived and locally produced T3 in the 
organs. The amount of T3 derived from plasma decreased in brown adipose tissue 
(BAT), heart, kidney, liver, muscle and pituitary. The amount of T3 produced locally 
decreased in BAT and brain. In the ovary an increase was found for T3 derived from 
both plasma and local production. The percentage local conversion (that is the %T3 
locally produced from T4 in relation to the total T3) was lower in BAT, whereas an 
increase was found for the ovary. For all other organs the percentage local conversi-
on remained constant. 
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Figure 1: Concentrations of T4 (A) and T3 (B) in brown adipose tissue (BAT), brain (Br), 
cerebellum (Cer), heart (H), kidney (K), liver (Li), muscle (M), ovary (Ov) and pituitary (Pit) 
from nonpregnant (solid bars) and 20-day pregnant (hatched bars) rats. Values are mean ± 
SE. * P < 0.05. 
The tissue-to-plasma ratio for T4 decreased in all tissues, except the heart and ovary 
(Table 3). For [131I]T3 the tissue-to-plasma ratio decreased in BAT, kidney, liver and 
pituitary, whereas it increased in the ovary (Table 4). Table 5 shows the ratio of 
[125l]T3-to-[125l]T4. This ratio increased for the brain, cerebellum, liver, muscle, ovary 
and pituitary. 
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Figure 2: Concentrations of T3 derived from plasma and produced locally in several organs 
(see figure 1) from nonpregnant (solid bars) and 20-day pregnant (hatched bars) rats. Values 
are mean ± SE. * P < 0.05. 
% Lc is the percentage local conversion (i.e. the percentage T3 locally produced from T4 in 
relation to the total T3) in nonpregnant (C) and 20-day pregnant (P) rats. 
Table 3: Tissue-to-plasma ratios for T4 in control and 20-day pregnant rats. 
BAT 
brain 
cerebellum 
heart 
kidney 
liver 
muscle 
ovary 
pituitary 
Controls 
0.144 ±0.019 
0.091 ±0.013 
0.160 ±0.027 
0.091 ± 0.009 
0.516 ±0.062 
1.017 ±0.072 
0.066 ± 0.007 
0.283 ± 0.029 
0.145 ±0.023 
Pregnant 
0.089 ±0.011 
0.049 ± 0.008 
0.041 ± 0.007 
0.080 ± 0.006 
0.319 ±0.025 
0.640 ± 0.035 
0.034 ± 0.002 
0.253 ± 0.012 
0.052 ± 0.012 
p value 
<0.05 
<0.01 
< 0.001 
ns 
<0.05 
< 0.001 
< 0.001 
ns 
< 0.005 
Data are expressed as means ± SE. 
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Tabel 4: Tissue-to-plasma ratios for [131I]T3 in control and 20-day pregnant rats. 
BAT 
brain 
cerebellum 
heart 
kidney 
liver 
muscle 
ovary 
pituitary 
Controls 
2.76 ± 0.30 
1.67 ±0.11 
2.17 ±0.19 
3.31 ± 0.32 
11.42 ±1.13 
7.35 ± 0.43 
1.60 ±0.15 
2.41 ± 0.30 
10.14 ±0.81 
Pregnant 
1.92 ±0.12 
1.80 ±0.22 
1.87 ±0.11 
2.90 ±0.13 
7.75 ± 0.53 
6.07 ± 0.29 
1.29 ±0.08 
4.13 ±0.23 
7.31 ± 0.63 
p value 
<0.05 
ns 
ns 
ns 
<0.05 
<0.05 
ns 
< 0.001 
<0.01 
Data are expressed as means ± SE. 
Table 5: Tissue [125l]T3-to-[125l]T„ ratios in control and 20-day pregnant rats. 
Controls Pregnant p value 
0.728 ±0.171 
0.796 ± 0.072 
0.473 ± 0.056 
0.594 ± 0.062 
0.390 ± 0.025 
0.137 ±0.010 
0.407 ± 0.047 
0.142 ±0.017 
1.341 ±0.180 
Data are expressed as means ± SE. 
DISCUSSION 
0.567 ± 0.075 
1.532 ±0.201 
1.916 ±0.315 
0.511 ±0.041 
0.444 ± 0.042 
0.186 ±0.012 
0.574 ± 0.060 
0.422 ± 0.041 
3.621 ± 0.837 
ns 
<0.01 
< 0.001 
ns 
ns 
<0.01 
<0.05 
<0.001 
<0.05 
In this study we were able to determine the contribution of local conversion of T4 to 
T3 in several tissues of the near-term pregnant rat. The method, the surgical proce-
dure to insert the cannula and the subsequent continuous infusion of [125I]T4 and 
[131I]T3 did not have a negative effect on pregnancy. This is demonstrated by the 
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normal bodyweight and number and weight of fetuses in the near-term pregnant rats. 
In accordance with previous reports pregnancy resulted in a decrease in plasma T4. 
In contrast, plasma T3 did not decrease significantly in this study (2, 12, 20). 
The plasma clearance rates for T4 and T3 were not altered significantly. However, 
when expressed per total animal instead of per 100 gram body wt an increase in the 
PCR for T4 was found. This is in agreement with the results of kinetic experiments 
(20). 
By expressing the production rates per total animal a more realistic comparison can 
be made between nonpregnant and near-term pregnant rats. In the pregnant rat the 
weight of maternal tissues is not increased in proportion to the bodyweight; the 
enormous gain in bodyweight is mainly due to the feto-placental compartment. 
However, this compartment does not contribute essentially to the production of 
maternal T4 and T3. 
Despite normal plasma TSH values the production of T3 by the thyroid is enhanced, 
in contrast to the thyroidal production of T4 which remained constant. Therefore, the 
T3-to-T4 ratio for thyroid hormones produced by the thyroid of the pregnant rat is 
increased. This pattern is also found during iodine deficiency (15), diabetes mellitus 
and modified fasting (17). On the other hand, the contribution of peripherally pro-
duced T3 entering the plasma decreased. This implies that less T3 was produced, or 
reached the plasma, in those organs which contribute to circulating T3, i.e. liver and 
kidney (4). The increase in thyroidal T3 production, and the decrease in peripherally 
produced T3 in the plasma together resulted in an unchanged plasma appearance 
rate. 
The amount of T4 decreased drastically in all organs. For some organs this had 
already been reported by Calvo et al. (2). The tissue-to-plasma ratio for T4 de-
creased in all organs except the ovary and heart. Therefore, the transport of plasma 
T4 to the maternal organs diminished, resulting in a tissue T4 concentration which 
was decreased even more than the plasma T4 level. In contrast, a marked increase 
in the transport from plasma to the fast pool has been found in kinetic experiments 
(20). However, in the normal situation the fast pool consists mainly of liver and 
kidney (3). We have already suggested that in the near-term pregnant rat the feto-
placental compartment also belongs to the fast pool (20). This implies that less T4 is 
available for the maternal organs, an hypothesis which is confirmed by the results of 
this study: the transport of T4 to the maternal organs decreased. 
For T3 the total tissue concentration diminished in all organs except the ovary, which 
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exhibited a pronounced increase in the T3 concentration. The ovary is the only organ 
in which the percentage T3 produced locally from T4 had increased in relation to the 
total T3. This could mean that the ovary is metabolically very active at the end of 
gestation. It is not clear why this occurs. 
The tissue-to-plasma ratio for plasma-derived T3 ([131I]T3) decreased in BAT, liver, 
kidney and pituitary, which means that less T3 was transported from plasma to these 
organs. This is also demonstrated by the decreased amount of plasma-derived T3 in 
these organs. 
The ratio of [125l]T3-to-[125l]T4 increased in the brain and cerebellum. Since the 
[125l]T3-to-[12Sl]T4 ratio is a marker for the activity of deiodinase enzymes, the activity 
of ID-II must have increased. This was confirmed by measurements of ID-II activity in 
the brain of near-term pregnant rats (2, 20). However, despite this increase in ID-II in 
the brain there was not an increase but a decrease in locally produced T3. This has 
to be explained by the decrease in T4 in the brain. In BAT the ratio of [12Sl]T3-to-
[125I]T4 remained unchanged, indicating that no alterations in ID-II activity occur in 
BAT during pregnancy. Therefore the decrease in the local production of T3 in BAT 
has to be the result of a diminished availability of precursor T4. 
The ratio of [125l]T3-to-[12Sl]T4 also increased in the liver, but not in the kidney which 
has to be the result of an increase in the activity of ID-I. It is known that the activity 
of deiodinase type I is increased in the liver of near-term pregnant rats (2, 20), 
indicating that an increased fraction of T4 is monodeiodinated to T3. In this way, 
despite the decrease in T4, a normal level of locally produced T3 could be reached in 
the liver. 
In conclusion: in the near-term pregnant rat normal tissue T3 values cannot be 
maintained. The tissue T4 concentrations are decreased so much that normal T3 
values cannot always be reached, not even in those organs in which deiodinase 
activity was elevated. Further regulation is not possible because there is not suffi-
cient T4 available for the local production of T3. Therefore, the transport of T4 to the 
feto-placental compartment results indirectly in a T3 deficiency in the maternal 
organs. 
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EFFECTS OF MARGINAL IODINE DEFICIENCY DURING PREGNANCY: 
IODIDE UPTAKE BY THE MATERNAL AND FETAL THYROID. 
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ABSTRACT 
Iodide uptake by the thyroid is an active process. Iodine deficiency and pregnancy 
are known to influence thyroid hormone metabolism. The aim of this study was to 
clarify the effects of iodine deficiency and pregnancy on iodide uptake by the thyroid. 
Radioiodide was injected intravenously into nonpregnant and 19-day pregnant rats 
receiving a normal or marginally iodine-deficient diet. The uptake of radioiodide by 
the thyroid was measured continuously for 4 h. The absolute iodide uptake by the 
maternal and fetal thyroids at 24 h was calculated by means of the urinary specific 
activity. Pregnancy resulted in a decrease in the absolute thyroidal iodide uptake. 
Marginal iodine deficiency had no effect on the absolute iodide uptake by the mater-
nal thyroid. The decreased plasma inorganic iodide was compensated by an in-
crease in thyroidal clearance. A similar compensation was not found for the fetus; 
the uptake of iodide by the fetal thyroid decreased by 50% during marginal iodine 
deficiency. This can lead to diminished thyroid hormone production, which will have 
a negative effect on fetal development, especially of the brain. 
thyroxine; 3,5,3'-triiodothyronine; plasma inorganic iodide; iodide kinetics. 
INTRODUCTION 
It is known that thyroid function is affected by various physiological conditions, for 
instance, food deprivation (24), pregnancy (10, 11, 12), and iodine deficiency (19, 
23). Iodide is an essential element for the production of thyroid hormones. The 
uptake of iodide by the thyroid gland is an active process that is regulated by thyr-
otropin (TSH) (26) and the thyroidal blood flow (3). Alterations in the thyroidal uptake 
of iodide can cause changes in the production of thyroid hormones. 
Iodine deficiency affects the physical and mental development of humans in large 
areas of the world (13). In rats it has been shown that during iodine deficiency the 
plasma thyroxine (T4) level decreased, while the 3,5,3'-triiodothyronine (T3) level 
remained unchanged (23). The weight of the thyroid and the T3-to-T4 ratio in the 
thyroid of rats on a low-iodine diet increased (19, 23). Studies of 10-day-old rats 
have shown that the thyroidal iodide uptake was considerably higher in iodine-
deficient rats than in controls (31 ). 
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Physiological changes in thyroid function also occur during pregnancy. Normal 
pregnancy in humans is accompanied by a rise in T4-binding globulin and total T4 
and T3 (12). However, the free T4 level is decreased at the end of gestation (29). The 
availability of iodide for the maternal thyroid is decreased because of increased 
renal clearance (1) and transport to the feto-placental complex during the late phase 
of gestation (10). The maternal thyroid is enlarged and the radioiodide uptake, 
expressed as a percentage of the dose, is increased during pregnancy (1, 10, 13). 
In the rat normal pregnancy results in a decrease in plasma total T4 and T3 concen-
trations (4). This is comparable to the decrease in free T4 in the third trimester of 
human pregnancy (29). The thyroidal uptake of 131l is decreased in the pregnant rat 
(9, 11, 15). No changes were found in the urinary excretion of iodide during the last 
days of gestation (9). Iodine deficiency induces a further decrease in plasma T4 in 
the near-term pregnant rat (8). Also the weight of the thyroid is increased by iodine 
deficiency in the pregnant rat (7). 
Most studies of the iodide uptake in rats are performed by giving a tracer injection of 
radioactive isotope of iodide (131l, 125l or 123l). After a certain period the thyroid is 
removed and the percentage of the injected radioactivity is calculated (9, 11,15, 31). 
In our laboratory we developed a method for measuring continuously the in vivo 
uptake of 12SI by the thyroid. By means of this method it is possible to study not only 
the amount of iodide taken up by the thyroid, but also the kinetics of the thyroidal 
uptake of iodide. We were also able to calculate the absolute iodide uptake by the 
thyroid. 
The aim of this study was to clarify the effects of pregnancy and iodine deficiency on 
iodide uptake by the thyroid. We used four groups of rats: nonpregnant and near-
term (day 19) pregnant rats receiving a normal iodine diet or a marginally iodine-
deficient diet. This marginally iodine-deficient situation closely reflects the iodine 
status in large populations of humans in the world. As previously described, preg-
nancy as well as iodine deficiency affects plasma thyroid hormone levels. However, 
the effects on the absolute iodide uptake by the thyroid are unknown. In particular 
iodine-deficient, near-term pregnant rats represent an important group. What are the 
effects of iodine deficiency on iodide metabolism in the near-term pregnant rat? Are 
the low amounts of iodide available taken up totally by the maternal thyroid or is 
there still iodide available for the fetuses? 
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MATERIAL AND METHODS 
Animals 
Three-month-old female Wistar rats (CPB/WU, IFFA CREDO, Brussels) were used. 
The rats were individually housed in metabolic cages at 22 °C, with alternating 14-h 
light and 10-h dark periods. The animals were fed a semisynthetic American Institute 
of Nutrition (AIN) diet (2) mixed with distilled water (60 % dry weight - 40 % water) 
and potassium iodide: 55 ng [normal iodine dose (NID)] or 2.9 ng [marginal iodine 
dose (MID)] per gram of feed. The marginally iodine-deficient groups received 1% 
KCI04 i n the drinking water during the first two days of the MID, at least four weeks 
before measurement was started. KCI04 was given to accelerate thyroidal depletion 
of total iodine stores. 
After two regular estrus cycles the rats were mated. Mating was confirmed by the 
presence of sperm in a vaginal lavage the following morning, called day 0 of 
pregnancy. 
Design of the study 
In this study four groups of animals were studied: 
1. nonpregnant rats on a normal diet (NID, C) 
2. pregnant rats on a normal diet (NID, P) 
3. nonpregnant rats on a marginally iodine-deficient diet (MID, C) 
4. pregnant rats on a marginally iodine-deficient diet (MID, P) 
The pregnant rats were assessed at the end of gestation, i.e. day 19. Fetuses are 
delivered on day 21. The more frequently used day 20 was not suitable in this 
experiment, because the animals were killed and bled twenty-four hours after the 
injection of radioiodide. 
Daily feed intake and urinary iodide excretion were determined for all rats. The mean 
feed intake was 30 g, resulting in a daily iodide intake of 1.3 ug for the NID groups 
and 66 ng for the MID groups. 
Urinary iodide was determined as described by Sandell and Kolthoff (22). 
The experiments were approved by the University Committee on Animal Care and 
Use of the Agricultural University of Wageningen. 
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Thyroidal iodide uptake 
The rat was anesthetized with xylazine (25 ul of 2 % rompunR/100 g body wt; sc), 
atropine (5 |jg/100 g body wt; sc) and ketamine (50 ul of 10 % ketamine/100 g body 
wt; ip). The anesthesized rat was fixed in a bed of plaster. The body temperature 
was controlled in the rectum and maintained at 38 °C by a warming jacket. 
The scintillation probe [type 42A. Nal crystal 23 mm, 1 mm thick, connected to mini-
Assay type 6-20 (Mini Instruments Ltd, Essex, UK)] was placed as close as possible 
to the thyroid region. 
To measure the thyroidal iodide uptake in the rat, a cannula inserted into the right 
vena jugularis (20) and a 400 ul bolus of saline containing 10 uCi carrier free Na125l 
(Amersham, Aylesbury, UK) was injected. The radioactivity taken up by the thyroid 
was measured automatically every thirty seconds for 4 h and calculated as a percen-
tage of the injected dose. The percentage dose of iodide taken up by the thyroid was 
fitted to the equation % dose = A [1-exp(-t/v)], by non-linear regression analysis 
using the program NLFIT/FIT4EXP, which is based on the Levenberger-Marquart 
method. 'A' represents the maximum percentage of dose taken up by the thyroid and 
Y is the time constant (min). 
Perchlorate discharge test 
To investigate the effects of Perchlorate on radioactivity in the thyroid three animals 
from each group underwent a perchlorate-discharge test (17). Four hours after the 
administration of Na-12Sl 10 mg/kg BW potassium Perchlorate was administrated i.p.. 
Thyroidal radioactivity was measured for another 30 minutes. 
Iodide kinetics in plasma 
To study the disappearance of the injected 1 2 5 l , plasma samples (50-100 ul blood) 
were taken via the cannula in the vena jugularis 1, 3, 5, 10, 16, 25, 40, 80, 150 and 
240 min. after injection of the 12S I . Radioactivity in the plasma samples was ex-
pressed as percentage dose per milliliter. 
The disappearance of iodide from plasma can be described by an exponential 
function. The data were fitted, together with the plasma volume at f(0), individually to 
sums of n=1 -3 exponentials (6) 
Y(t)= A, exp(A1*t)+ A2 exp(X2*t) + A3 exp(A3*t) 
using the program DIMSUM, whereby Ai coefficients are expressed as percentage 
dose per milliliter and exponents Af are expressed per minute (16). 
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Absolute iodide uptake after 24 h. 
After measurement the rats were placed in metabolic cages to collect urine. 
Twenty-four hours after injection of the 125l the rats were killed by bleeding and 
perfusion with saline under ether anesthesia. The maternal thyroid, mammary gland, 
placentas and fetuses were removed. The fetal thyroid was collected by excising that 
part of the trachea containing the thyroid. 
All radioactivities measured (i.e., maternal and fetal thyroid, plasma, urine, mammary 
gland, placentas and fetuses minus thyroid at 24 h) were expressed as percentages 
of the injected dose. 
The assumption can be made that, during a steady state situation the specific activ-
ity of iodine (ratio of 125l to 127l) in urine is the same as that in the plasma from which 
it originated (28). The absolute iodide uptake (AIU) by the maternal and fetal thy-
roids, mammary gland, placentas, and fetuses minus thyroid as well as the plasma 
inorganic iodide (Pll) can be calculated after determination of the specific activity in 
urine (1). 
% dose after 24 hr 
AIU = (= ng/ 24 hr.). 
% dose urine/ng iodide urine 
% dose/ml plasma 
Pll = (= ng/ml). 
% dose urine/ng iodide urine 
Radioiodide clearance by the thyroid (CTh) and by the kidneys (CR) is calculated from 
the increment between 120 and 240 min divided by the radioactivity in a plasma 
sample collected simultaneously (1). 
% dose/min in thyroid 
CTh = ( = ml/min). 
% dose/ml plasma 
% dose urine 
CR = ( = ml/min). 
% dose/ml plasma * 1440 min 
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Statistical analysis 
All data are expressed as means ± SE. Data were analyzed using the Statistical 
Package for Social Sciences (25). All data were subjected to one-way analysis of 
variance and statistical differences between groups were determined using the least 
significant difference method. 
RESULTS 
Marginal iodine deficiency had no effect on either the bodyweight of the rats or the 
number of fetuses. No significant alterations were found for plasma TSH. Plasma T4 
and T3 did not change significantly during marginal iodine deficiency. Pregnancy 
resulted in a decrease in plasma T4 and T3 in NID as well as MID rats (Table 1). 
Table 1: Bodyweight and plasma thyroid hormone concentrations. 
Body weight, g 
# fetuses 
T4, nM 
T3,nM 
TSH, ng/ml 
NID, C 
(n=13) 
229 ±4 
31.4 ±0.6 
0.55 ± 0.04 
0.51 ±0.09 
NID, P 
(n=10) 
300 ± 5* 
11 ±1 
21.2 ±1.5* 
0.49 ± 0.03* 
0.48 ± 0.07 
MID, C 
(n=8) 
235 ±4 
29.5 ± 2.4 
0.69 ± 0.06 
0.75 ± 0.05 
MID, P 
(n=8) 
304 ± 6* 
11 ±1 
16.9 ±2.0* 
0.47 ± 0.04* 
0.65 ± 0.09 
Values are means ± SE. NID and MID, normal and marginal iodine dose, respectively; C, 
control rats; P, near-term pregnant rats; T4, thyroxine; T3, 3,5,3'-triiodothyronine; TSH, thyrot-
ropin. * P < 0.05, P vs. C. 
Feed intake and urinary iodide excretion 
At the start of the experiments, the marginally iodine-deficient groups received 
potassium Perchlorate for 2 days. The effect of this treatment on urinary iodide 
excretion is shown in Fig. 1. Potassium Perchlorate treatment from day 0 to day 2 
resulted in an increase in iodide excretion. Within 1 wk after Perchlorate treatment 
urinary iodide excretion had decreased to 0.4 ug/day; it remained constant during 
the rest of the experimental period. 
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Figure 1 : Effect of KCI04 treatment on the 24-h urinary iodide excretion in marginally iodine-
deficient nonpregnant rats. 
The mean feed intake and urinary iodide excretion for the four groups of rats are 
shown in Fig. 2. No effect of MID on feed intake was found. During pregnancy feed 
intake and urinary iodide excretion increased . 
NID NID MID MID 
C P C P 
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Figure 2: Effect of marginal iodine deficiency and pregnancy on the daily feed intake (A) and 
urinary iodide excretion (B). P<0.05: # pregnant (P) vs. control (C); 
* marginal iodine dose (MID) vs. normal iodine dose (NID). 
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Thyroidal 125l uptake 
Table 2 shows the data on thyroidal 125l uptake. The weight of the thyroid increased 
significantly in both marginally iodine-deficient groups; pregnancy had no effect on 
the weight of the thyroid. 
Table 2: Weight of thyroid and parameters of uptake of radioiodide by thyroid. 
NID, C NID, P MID, C MID, P 
(n=17) (n=23) (n=15) (n=15) 
Thyroid, mg 17.3 ±1.8 17.4 ±1.0 27.3 ±1.5® 23.5 ±1.1® 
Uptake 
4-h, %dose 21.2 ±1.7 13.4 ±1.1* 52.3 ±4.2® 35.7 ± 3.8*® 
A, %dose 26.9 ±2.2 16.0 ±1.2* 51.3 ±9.5® 42.2 ±4.4*® 
Y, min 166 ±20 139 ±9 125 ±16 112 ±15 
Values are means ± SE. A, maximum %dose taken up by the thyroid; v, time constant. 
P < 0.05: * P vs. C; ® MID vs. NID. 
The 4-h 125l uptake by the thyroid increased in C and P MID rats. Pregnancy induced 
a decrease in 12SI uptake by the thyroid in both NID and MID rats. The 4-h 125l up-
take is a direct measurement of the thyroid; A and y are the results of fitting the data 
to the one-exponential function %dose=A [1-exp(-t/Y)]. Two- and three-exponential 
functions did not yield satisfactory results. The time constant (y) of the 125l uptake 
was unchanged in all groups. The mean fitted thyroidal 125l uptake is given in Fig. 3, 
where we also see that the thyroidal 125l uptake was lower in P rats and increased in 
the MID groups. 
Perchlorate discharge test 
No discharge of radioiodide from the thyroid was found for any of the four groups. 
The radioactivity of the thyroid remained unchanged (results not shown). 
Iodide kinetics in plasma 
Table 3 shows the parameters of iodide kinetics in plasma. No significant changes 
were found except for A, in pregnant rats. 
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Figure 3: Fitted 4-h thyroidal radioiodide uptake based on mean maximal %dose taken up (A) 
and time constant (y) values. 
AIUafter24h. 
Table 4 shows the specific activity of urine and the results of calculations of the AIU 
by the maternal thyroid, Pll, CTh and CR. The urinary specific activity was un-
changed during pregnancy, but marginal iodine deficiency caused an increase in 
specific activity. The AIU by the thyroid was decreased by pregnancy, while marginal 
iodine deficiency had no effect on the AIU. Pll was decreased in the MID groups, 
whereas pregnancy had no effect. Unidirectional iodide CTh was increased in the 
MID groups. CR was increased by pregnancy, whereas MID resulted in a decrease 
in CR in C and near-term P rats (Table 4). 
The AIU values at 24 h by the maternal thyroid, placentas, fetal thyroids, remaining 
part of the fetuses and mammary gland are shown in Fig. 4. Whereas MID had no 
effect on the AIU by the maternal thyroid, a pronounced decrease was found for the 
fetal thyroids and the remaining part of the fetuses. The amount of iodide taken up 
by the mammary gland was also decreased by MID, whereas no significant effect 
was found for the placentas. 
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Figure 4: Absolute iodide uptake by the maternal thyroid and feto-placental compartment; 1. 
placentas; 2. fetal thyroids; 3. fetuses minus thyroids; 4. mammary gland (1 g). * P<0.05: 
NID.Pvs. MIDP. 
DISCUSSION 
The process by which the thyroid gland adapts to an insufficient iodine supply is to 
increase the trapping of iodide. When iodine intake is low, adequate secretion of 
thyroid hormones may still be achieved by marked modifications of thyroid activity. 
The thyroid is stimulated by an increased thyroid blood flow (3) and TSH (19, 23). 
The T3-to-T4 ratio of iodothyronines secreted by the thyroid is increased during 
iodine deficiency, especially because of a decrease in T4 production (23). 
Marginal iodine deficiency was induced in our rats by feeding them a MID diet. 
Within 2 wk of the start of the MID diet, urinary iodide excretion remained at the 
same level. So, at the moment of measurement, at least 4 wk after start of the MID 
diet, the rats were in a steady state. The fact that only a marginal iodine-deficient 
state was achieved, and not a severe iodine-deficient state, situation is demonstra-
ted by the unchanged plasma T4 and T3 levels. Despite a slight increase in plasma 
TSH, the weight of the thyroid had already increased by 50%. The unchanged 
number of fetuses during pregnancy also demonstrates that the induced iodine 
deficiency was not severe (8). 
In this study we were able to measure thyroidal radioiodide uptake continuously. For 
the kinetic analysis of radioiodide uptake in the human thyroid a three-compart-
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mental model is used (3, 14, 30). In this model, a plasma iodide pool and an inor-
ganic and an organic thyroidal iodide pool can be distinguished. We tried to fit our 
data to this model; however, our data could only be fitted to a one-exponential 
function. Therefore, we assume that, even in euthyroid rats, iodide transport from 
plasma into the thyroid is unidirectional because of an extremely avid iodine organ-
ification. This idea is confirmed by the total absence of a Perchlorate discharge in all 
rats, meaning that there is no efflux of inorganic iodide from the thyroid (17). 
The thyroidal uptake of radioiodide was stimulated by marginal iodine deficiency. 
The kinetic analysis shows that the time constant for thyroidal radioiodide uptake 
was not affected by iodine deficiency, meaning that the time needed to achieve the 
maximum effect remained the same. However, the AIU by the thyroid remained 
normal. This was achieved by an increased CTh resulting from the increased thyroid 
volume and thyroidal blood flow (3). 
The urinary specific activity was increased, whereas the radioiodide activity in 
plasma was not altered by marginal iodine deficiency. This resulted in a Pll that was 
significantly lower, such as is found in humans residing in areas of iodine deficiency 
(5) and in 10-day-old iodine deficient rats (31 ). 
Our observations emphasize the need for caution in interpretation of results ob-
tained by studies measuring the thyroidal radioiodide uptake only. We have demon-
strated that a decrease or increase in radioiodide uptake does not automatically 
mean that the AIU has changed. 
Also during normal pregnancy changes in iodide metabolism are found. The urinary 
iodide excretion was higher for P than C rats of the NID as well as MID groups. This 
can be explained by the increased feed intake and the increase in CR. Galton (11 ) 
also found an increased urinary iodide excretion for pregnant rats during the last 
days of gestation (11). 
At the end of gestation the percentage radioiodide taken up by the thyroid was 
significantly decreased. This has also been reported for rats with a normal iodine 
intake (9, 11, 15). Because the urinary specific activity was not altered by preg-
nancy, this also resulted in a decrease in the absolute iodide uptake by the maternal 
thyroid at the end of gestation in NID as well as MID rats. It seems that the thyroid of 
the near-term P rat has less iodide available for the production of thyroid hormones. 
However, no change in thyroidal hormone production is found at the end of gestation 
(27). This would seem to imply that the use of iodide in the thyroid of the near-term P 
rat is more efficient or that the thyroglobulin stores are depleted. 
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The difference in thyroidal iodide uptake between C and near-term P rats cannot be 
attributed entirely to the increase in urinary iodide excretion. We suggest that the 
remaining part of the iodide is used by the mammary glands and the feto-placental 
compartment. For lactating rats it has been shown that, 4 h after injection, the mam-
mary glands contain as much radioiodide as the thyroid, and it was suggested that 
during pregnancy radioiodide was already being transported to the mammary glands 
(15). The latter was contradicted by our measurements. One gram of the mammary 
gland had only taken up 6.5 ng iodide at 24 h; this is less than 1% of the thyroidal 
uptake. 
The placenta possesses a mechanism for actively transporting iodine (21). There-
fore, it is to be expected that a certain amount of radioiodide is transported to the 
fetal compartment. Our results, collected 24 h after injection, show that the fetal 
thyroid is capable of concentrating iodide on day 20 of pregnancy. The thyroidal 
region of the fetus contained as much iodide as the rest of the fetus. However, the 
total amount of iodide in placentas and fetuses could not explain the decreased 
uptake of iodide by the maternal thyroid. Therefore, the feto-placental compartment 
and the mammary glands are not the only factors responsible for the difference in 
maternal thyroidal iodide uptake. 
During marginal iodine deficiency the AIU of the maternal thyroid remained normal. 
However, there was already a tendency toward a shift in thyroid hormone synthesis; 
T4 decreased and T3 remained normal. In contrast to the maternal thyroid no com-
pensation, by an increased thyroid clearance for the decreased Pll concentration 
was found for the fetal thyroid. The AIU by the fetal thyroid was decreased by 50%. 
This pattern can lead to lower T4 availability for the fetus. This is supported by 
kinetic studies of marginally iodine-deficient, near-term pregnant rats showing that 
the maternal transfer of T4 and T3 to the fetuses is decreased during marginal iodine 
deficiency (unpublished data). As long as the increase in type II deiodinase is suf-
ficient to maintain normal T3 values in the fetal brain, problems need not be expected 
(18). If this is not achieved, defects in brain development will occur. 
In conclusion: During pregnancy the AIU by the maternal thyroid gland is decreased. 
Marginal iodine deficiency does not affect the maternal AIU. The low availability of 
iodide was compensated by increased activity of the maternal thyroid, whereas fetal 
thyroidal uptake of iodide decreased by 50%. The fetus is apparently not able to 
regulate its iodide metabolism in case of marginal iodine deficiency. Therefore, this 
level of marginal iodine deficiency, despite the near euthyroid status of the mother, 
already has an effect on the availability of iodide for the fetus. This can mean that 
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fetal T< production is markedly diminished at a time when it is of eminent importance 
for the normal development of many organs, especially the brain. 
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ABSTRACT 
During pregnancy maternal thyroid hormones are of great importance for normal 
development of the central nervous system of the fetus. Iodine deficiency of the 
mother can result in an impaired development of the fetal brain. In large areas of the 
world the iodine intake is moderately low. To study the effects of marginal iodine 
deficiency (MID) on the production, distribution, and transport of thyroxine (T4) and 
3,5,3'-triiodothyronine (T3) in nonpregnant and near-term pregnant rats we per-
formed kinetic experiments (three-compartment analysis). Despite unchanged 
plasma T4 and T3 during MID, the production and plasma clearance rates of T4 
decreased, while these values for T3 increased in nonpregnant rats. Hepatic de-
iodinase type I activity increased during MID. It appears that during MID rats are 
able to maintain their euthyroid status. The pronounced increase in transport of T4 
from plasma to the fast pool observed in normal pregnant rats did not occur during 
MID. The alterations in T3 metabolism due to MID in pregnant rats were the opposite 
of those found for nonpregnant rats. 
Conclusion: Marginal iodine deficiency affects maternal thyroid hormone metabo-
lism, thus influencing the availability of maternal T4 for the fetuses. 
INTRODUCTION 
In large areas of the world iodine intake is insufficient. Severe iodine deficiency can 
result in miscarriage, stillbirth, and congenital anomalies as well as the more familiar 
goiter, cretinism, impaired brain function and hypothyroidism in children and adults 
(15). 
In rats iodine deficiency can be induced by prolonged administration of a low iodine 
diet. This treatment results in a markedly increased weight of the thyroid. The T3-to-
T4 ratio in the thyroid as well as the T3-to-T4 ratio secreted by the thyroid increased 
progressively with the duration of iodine deficiency (12, 23). In the iodine-deficient 
rat plasma T4 is decreased and plasma thyrotropin (TSH) increased while circulating 
T3 remains normal (26). Since T3 in the brain is generated mainly by local conversion 
from T4 (8), normal circulating T3 levels, in combination with low plasma T4, are not 
sufficient to maintain euthyroidism in the brain (22). 
Pregnancy also influences the thyroid hormone status. In humans normal pregnancy 
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is accompanied by a rise in the serum levels of total T4 and T3. However, due to a 
rise in T4-binding globulin the free T4 and T3 levels decrease during pregnancy (11, 
32). In the rat normal pregnancy also results in a decrease in plasma T4 and T3 (5, 
29). This leads to reduced concentrations of T4 and T3 in the maternal tissues, 
except for T3 in the brain (5). The clearance of T4 from plasma is increased markedly 
which can be a result of the transport of T4 to the fetal compartment (29). 
Thyroid hormones are known to play an important role in brain maturation. Their 
absence during fetal development leads to irreversible brain damage. Studies of 
pregnant rats on a low iodine diet by the Madrid group revealed that when iodine 
deficiency is severe enough to cause very low maternal plasma T4 levels, fetal 
plasma and tissues will suffer a shortage of T4 and T3 both before and after onset of 
fetal thyroid function (9, 21). During normal pregnancy mainly T4 is transported from 
mother to fetus (4). In severely hypothyroid pregnant rats only T4 can mitigate fetal 
T4 and T3 deficiency (3). In the fetal brain T4 is necessary for the local generation of 
T3 from T4 by cerebral type II deiodinase (ID-II) (21 ). 
Most experimental studies are performed during severe iodine deficiency. However, 
in large populations in the world the iodine intake is only marginally iodine-deficient. 
Data about the effects of marginal iodine intake on thyroid hormone metabolism are 
lacking. Therefore, we induced an iodine deficiency in rats such marginal that growth 
and reproduction outcome were not affected. The aim of this study was to determine 
the effects of marginal iodine deficiency on thyroid hormone metabolism in nonpreg-
nant and near-term pregnant rats. T4 and T3 production, distribution, and transport 
were examined by performing a kinetic study using the three-compartment model of 
distribution and metabolism developed by DiStefano et al. (6, 7). In this model three 
compartments can be distinguished. 1 ) the plasma; 2) tissues that exchange T4 and 
T3 with plasma at a fast rate, i.e. the fast pool; and 3) the slow exchanging pool, the 
slow pool. Liver and kidney are presumed to be the main components of the fast 
pool, whereas skin, muscle, and brain belong to the slow pool (6, 7). 
By means of this model we have already described the production, distribution, and 
transport of T4 and T3 in near-term pregnant rats on a normal iodine diet; we sug-
gested that T4 is transported very rapidly from plasma to the feto-placental compart-
ment (29). In this study we will concentrate on the effects of marginal iodine defi-
ciency on maternal thyroid hormone metabolism. Does a marginal iodine deficiency 
affect the availability of thyroxine for the feto-placental compartment ? 
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MATERIAL AND METHODS 
Animals and diet 
Three-month-old female Wistar rats (CPB/WU, Iffa Credo, Brussels) were used. The 
animals were individually housed at 22 °C, with alternating 14-h light and 10-h dark 
periods. The rats were fed a semi-synthetic American Institute of Nutrition (AIN) diet 
(2). The dry feed was mixed with distilled water (60 % dry weight- 40 % water) with 
the addition of potassium iodide: 55 ng (normal iodine diet; NID) or 2.9 ng (marginal 
iodine diet; MID) per gram of feed. The iodine-deficient groups received 1% KCI04 in 
their drinking water during the first two days of the MID. KCI04 was given to accele-
rate thyroidal depletion of total iodine stores. 
The rats were mated after at least two regular estrus cycles. The day that sperm 
appeared in the vaginal smear was taken as day 0 of gestation. The gestational 
period of the rat is 22 days. 
Design of the study 
MID treatment was started at least two weeks before mating for the pregnant groups 
and minimally five weeks before measurements for the nonpregnant groups. Surgery 
(insertion of the cannula) was conducted one week before measurements. 
There were four groups of rats: 
1. nonpregnant rats on a normal diet ; NID-C. 
2. pregnant rats on a normal diet ; NID-P. 
3. nonpregnant rats on a marginal iodine-deficient diet ; MID-C. 
4. pregnant rats on a marginal iodine-deficient diet ; MID-P. 
Daily feed intake and urinary iodide excretion were determined for all rats. The mean 
feed intake was 30 gram, resulting in a calculated daily iodide intake of 1.3 ug for the 
NID groups and 66 ng for the MID groups. 
Kinetic experiments were performed on day 19 of gestation. After the kinetic experi-
ment the animals were killed and maternal and fetal liver and brain were collected. 
The experiments were approved by the University Committee on Animal Care and 
Use of the Agricultural University of Wageningen. 
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Kinetic and analytical protocols 
[125I]T4 and [131I]T3 (specific activity 80 and 130 Mbq/ug (2200 and 3500 uCi/ug), 
respectively) were prepared in our laboratory (2, 18). Na125l and Na131l were obtained 
from Amersham (Arlington Heights, IL); L-T3 and 3,5-L-diiodothyronine, the respect-
ive substrates for labelling, were purchased from Sigma (St. Louis, MO). Purity of the 
tracers was assessed by means of HPLC. 
Via a cannula inserted into the right jugular vein (24) the rats received a 400 ul bolus 
injection of a solution of 3700 Bq (10 uCi) [125I]T4 and 3700 Bq (10 uCi) [131I]T3 in 
saline containing heparin (0.3 U/ml; Organon, Tilburg, The Netherlands), ticarcillin 
(0.4 mg/ml; Ticarpen, Beecham S.A., Heppignies, Belgium) and 5 % normal rat 
serum. Ticarcillin is added to solutions containing labelled iodothyronines to prevent 
eventual bacterial infections and reduce artefactual deiodination, as described by 
Van Doorn (8). 
From the canula in the jugular vein blood samples of 0.2 ml were taken at 1, 4.5, 10, 
23, 44, 115, 202 and 315 min; 0.4 ml. were drawn at 465, 600, 900, 1200 and 1440 
min, being the optimal time schedule according to DiStefano et al. (6, 7). 
Fifty to hundred microliters plasma (in duplicate) were used to count the total 131l and 
125l activities. The plasma samples were extracted with ethanol/ammonia (25 
%)(197:3 v/v) with 0.1 mM propylthiouracil (PTU). The dried extracts were dissolved 
in 0.1 ml 0.2 M ammonia containing carrier T4, T3 and Kl (1 mg/10 ml) and subjected 
to HPLC to separate the iodothyronines, according to the method described by 
Schröder-van der Eist and van der Heide (27). 
The endogenous concentrations of T4 and T3 in plasma were measured by means of 
a specific rat RIA (14) of samples taken before the kinetic experiment was per-
formed. 
Plasma TSH was measured by the specific RIA developed for the rat by the National 
Institute of Diabetes and Digestive and Kidney Diseases of the National Institute of 
Health (USA). Reference preparation RP-2 was used as a standard. 
Calculations 
The percentage doses of [131I]T3 and [125I]T4 per ml plasma were calculated from the 
total radioactivities and the [131I]T3 and [125I]T4 distributions on the HPLC chromato-
gram. The percentage doses per ml, together with the plasma volume at t(0) (16, 
29), were fitted individually to sums of n=1 to 3 exponential: 
Y(t)= A, exp(Vt) + A2 exp(A2*t) + A3 exp(A3*t) 
using the program DIMSUM, whereby A, is expressed in %dose/ml, \ in min'1 (20). 
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To calculate the parameters of production, distribution and metabolism the program 
MAMPOOL (19) was used. The sum of the three exponential functions was fitted (by 
weighted least squares regression analysis) to the data collected for each individual 
rat and, together with plasma J4 and T3 levels, substituted into the three-com-
partment model, according to the kinetic T4 and T3 studies of DiStefano et al, (6, 7). 
All data are expressed as mean ± SE. Statistical analysis was performed by the 
Student's Mest using the Statistical Package for Social Sciences (SPSS) (28). 
Analytical determinations 
Urinary iodide was determined as described by Sanded and Kolthoff (25). 
Mitochondrial and cytosolic fractions from liver and brain were obtained by differenti-
al centrifugation, according to the separation scheme described by van Doorn (8). 
Liver and brain mitochondrial alpha-glycerophosphate dehydrogenase (a-GPD) was 
measured by means of the method described by Garrib and McMurray (10). 
Cytosolic malic enzyme (ME) was determined for liver and brain according to the 
method of Hsu and Lardy (16). 
The determination of type I deiodinase (ID-I) activity in liver homogenates was 
performed by the method described by Janssen et al. (17). 
Protein was determined by the bicinchoninic acid (BCA) method (Pierce Europe, 
Oud Beijerland) using BSA as standard. 
RESULTS 
Urinary iodide excretion 
The effect of treatment with 1 % KCI04 for two days is demonstrated in Fig. 1a. 
Within a week after Perchlorate treatment urinary iodide excretion had decreased to 
0.4 ug/day; it remained constant during the rest of the experimental period. Fig. 1b 
shows the daily urinary iodide excretion four weeks after the start of the diet. MID 
resulted in a sharp decrease in urinary iodide excretion. No effect of pregnancy on 
urinary iodide excretion was present in NID and MID rats. 
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Figure 1: The effect of KCI04 treatment on the 24 h urinary iodide excretion (A) and the daily 
urinary iodide excretion (B). Values are means ± SEM. P < 0.05, * MID vs. NID. 
Body weight and plasma hormones 
Table 1 shows the body weight (BW) and plasma thyroid hormone and TSH levels. 
Marginal iodine deficiency had no significant effect on maternal BW and the number 
of fetuses. During pregnancy the plasma T4 and T3 decreased; plasma TSH did not 
change significantly. This applied for NID as well as MID rats. During marginal iodine 
deficiency plasma T4 and T3 values were unchanged in nonpregnant as well as in 
pregnant rats; plasma TSH was increased significantly in nonpregnant rats only. 
Table 1 : Body weight and plasma thyroid hormone concentrations. 
Values are means ± SE M 
Body wt (g) 
No. of fetuses 
T4 (nmol/l) 
T3 (nmol/l) 
TSH (ng/ml) 
P < 0.05: * P vs. C; 
NID-C 
(n=6) 
211 ±6 
33.8 ± 2.2 
0.62 ± 0.04 
0.28 ± 0.08 
® MID vs. NID. 
MID-C 
(n=9) 
229 ±6 
34.6 ± 3.0 
0.73 ± 0.06 
0.75 ±0.10® 
NID-P 
<n=8) 
304 ± 6' 
11 ±1 
22.5 ±1.5* 
0.53 ± 0.06 
0.49 ± 0.06 
MID-P 
(n=6) 
323 ± 9' 
11 ±1 
17.2 ±1.7' 
0.44 ± 0.04" 
0.65 ± 0.09 
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T4 kinetics 
The effect of pregnancy on the fractional turnover and transport rates of T4 was 
similar for NID and MID rats; T4 disappeared more quickly from all three pools in 
pregnant rats. No effects of marginal iodine deficiency on the kinetic parameters of 
T4 were found (data not shown). 
The mean results of distribution volumes, pool sizes, and transport rates of T4 are 
summarized in Table 2. 
Table 2: Parameters of distribution, volumes, pool sizes, and rates of transport of T4 (expres-
sed per 100 g body weight). Values are means ± S.E.M. 
PCR (ml/h) 
PR (pmol/h) 
Vtotal (ml) 
Vp (ml) 
V2 (ml) 
V3 (ml) 
Qtotal (pmol) 
Qp (pmol) 
Q2 (pmol) 
Q3 (pmol) 
TRpf (pmol/h) 
TRfp (pmol/h) 
DRfo (pmol/h) 
TRps (pmol/h) 
TRsp (pmol/h) 
DRso (pmol/h) 
NID-C 
1.38 ±0.06 
47.2 ± 4.2 
17.9 ±0 .6 
4.9 ± 0.1 
4.3 ± 0.3 
8.7 ± 0.6 
615 ±51 
166 ±12 
145 ±12 
303 ± 33 
973 ±114 
952 ±115 
23.6 ±2 .1 
162 ± 2 3 
138 ±21 
23.6 ±2.1 
MID-C 
0.93 ± 0.07® 
31.9 ±3.4® 
16.1 ±0 .5 
4.5 ±0 .1 
4.5 ±0 .3 
7.1 ±0 .5 
546 ± 3 4 
156 ± 11 
152 ±12 
239 ± 1 8 
1392 ± 363 
1376 ± 363 
16.0 ±1.7® 
108 ±20 
92 ±18 
16.0 ±1.7® 
NID-P 
1.73 ±0.04* 
38.6 ±2.5 
18.1 ±0.8 
4.9 ±0.1 
4.0 ± 0.3 
9.2 ±0 .5 
421 ± 32" 
110 ±7* 
89 ±9" 
207 ±17" 
2574 ±317* 
2563 ±313" 
19.8 ±1 .3 
188 ±32 
169 ±31 
19.8 ±1.3 
MID-P 
1.79 ±0.17" 
30.4 ± 3.0 
15.9±1.5 
4.7 ±0.2 
3.6 ±0.7 
7.6 ±1 .0 
274 ± 35' ® 
82 ± 8*® 
65 ±17* 
127 ±16"® 
1250 ±249® 
1233 ±250® 
15.4 ±1 .4 
124 ± 4 4 
109 ± 4 5 
15.4 ±1.4 
PCR, plasma clearance rate; PR, production rate; V, plasma equivalent distribution volume; 
Q, pool quantity; TRpf, TRfp, TRps, and TRsp, rates of transport between plasma and the fast 
and slow pools respectively, in each direction; DRfo and DRso, disposal rate from fast and 
slow pool respectively; % PF and %PS, fraction of T„ in plasma transported unidirectionally to 
the fast and slow tissue pools respectively; p, plasma; 2, fast pool; 3, slow pool. 
P < 0.05: ' P vs. C; ® MID vs. NID. 
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In pregnant rats the plasma clearance rate of T4 is increased. A decreased plasma 
clearance rate due to marginal iodine deficiency was found for nonpregnant MID rats 
but not pregnant MID rats. 
The production rate of T4 remained unchanged during pregnancy. Marginal iodine 
deficiency resulted in a decrease in T4 production, which was significant for nonpreg-
nant rats only. 
The distribution volumes of T4 were not affected by pregnancy or marginal iodine 
deficiency. 
The total amount of T4 decreased in the pregnant groups. This decrease was found 
in all three pools. Marginal iodine deficiency induced a further decrease in T4 pool 
sizes for the pregnant rats; for nonpregnant rats no effect of marginal iodine defi-
ciency was found. 
The transport of T4 changed only in pregnant rats on a normal iodide diet. Transport 
to the fast pool and vice versa were more than doubled. This effect of pregnancy 
was not found in the MID group. The disposal of T4 decreased in both nonpregnant 
and pregnant rats. 
The transit times for the three pools and the total residence time for T4 are shown in 
Table 3. In pregnant rats the transit times for T4 in plasma and the fast pool decrea-
sed. The total residence time also decreased. Marginal iodine deficiency results in 
an increase in the total residence time for T4 in nonpregnant rats only. 
Table 3: Transit times and total residence time for T.. Values are means ± S.E.M. 
Transit time, min 
Plasma 
Fast pool 
Slow pool 
Total residence time 
P<0.05:*Pvs. C;® 
, min 
MID vs. NID. 
NID-C 
9.5 ±0.8 
9.7 ± 1.1 
127 ±15 
789 ± 30 
MID-C 
9.1 ±1.5 
10.1 ±1.8 
166 ±24 
1079 ±73® 
NID-P 
3.7 ± 0.9* 
3.5 ±1.2' 
99 ±23 
616 ±20' 
MID-P 
4.5 ±1.1* 
4.2 ±1.5* 
154 ±90 
560 ±86 
T3 kinetics 
For T3 almost no significant alterations were found in the kinetic parameters. Only in 
pregnant MID rats a decrease of the transport rate from plasma to the fast pool, due 
to marginal iodine deficiency, was found (data not shown). 
Table 4 shows the distribution volumes, pool sizes, and transport rates of T3. 
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Table 4: Parameters of distribution volumes, pool sizes, and transport rates of T3 (expressed 
per 100 g body wt). Values are means ± S.E.M. 
PCR (ml/h) 
PAR (pmol/h) 
PR (pmol/h) 
Vtotal (ml) 
Vp (ml) 
V2 (ml) 
V3 (ml) 
Qtotal (pmol) 
Qp (pmol) 
Q2 (pmol) 
Q3 (pmol) 
TRpf (pmol/h) 
TRfp (pmol/h) 
DRfo (pmol/h) 
TRps (pmol/h) 
TRsp (pmol/h) 
DRso (pmol/h) 
NID-C 
21.7 ±2.1 
13.4 ±1.5 
14.6 ±1.7 
209 ± 20 
4.8 ±0.1 
28.6 ±2.1 
176 ±19 
128 ± 11 
3.0 ±0.2 
17.5 ±1.0 
108 ± 11 
214 ± 15 
207 ±15 
6.7 ±0.8 
53 ±7 
55 ±7 
8.0 ±0.9 
MID-C 
36.6 ± 5.4e 
27.6 ± 5.0® 
32.2 ± 6.5e 
278 ± 21® 
4.8 ±0.6 
35.1 ±5.1 
238 ± 21 
216 ± 24e 
3.4 ±0.3 
24.4 ±2.9 
176±25e 
256 ± 30 
242 ± 28 
13.8 ± 2.5e 
81 ±13 
85 ±13 
18.5 ± 4.0e 
NID-P 
26.1 ±2.8 
13.3 ±1.1 
14.6 ±1.2 
194 ±15 
4.9 ±0.1 
33.1 ±4.3 
180 ±27 
111 ±13 
2.6 ±0.3 
17.2 ±2.5 
92 ±14 
229 ± 34 
222 ± 34 
6.6 ±0.6 
56±11 
58 ±11 
8.0 ±0.6 
MID-P 
24.9 ± 2.4 
10.3±0.4*e 
11.4±0.5*e 
224 ± 39 
4.8 ±0.2 
24.9 ±3.4 
194 ±37 
95 ± 18* 
2.1 ±0.2* 
10.6±1.4*e 
83 ±17* 
100±20*e 
95 ± 20*e 
5.1 ± 0.2*e 
44 ±4* 
47 ±5* 
6.3 ± 0.3*e 
PCR, plasma clearance rate; PAR, plasma appearance rate; PR, production rate; V, plasma 
equivalent distribution volume; Q, pool quantity; TRpf, TRfp, TRps, and TRsp, rates of trans-
port between plasma and the fast and slow pools respectively, in each direction; DRfo and 
DRso, disposal rate from fast and slow pool respectively; % PF and %PS, fraction of T3 in 
plasma transported unidirectionally to the fast and slow tissue pools respectively; p, plasma; 
2, fast pool; 3, slow pool. 
P < 0.05: " P vs. C; e MID vs. NID. 
The plasma clearance rate of T3 increased in the nonpregnant MID group only. 
Pregnancy resulted in a decrease in T3 production in MID rats. The effects of margi-
nal iodine deficiency on the production of T3 were conflicting. In nonpregnant MID 
rats we found an increase, while in pregnant MID rats the T3 production decreased 
slightly. 
The transport of T3 from plasma to the fast pool and vice versa decreased in preg-
nant MID rats only. The disposal of T3 increased in nonpregnant MID rats. Marginal 
iodine deficiency induces in pregnant rats'even a decrease in the disposal of T3. 
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In pregnant MID rats the increased transit time for T3 in plasma was the only change 
in transit times and total residence time found for T3 (Table 5). 
Table 5: Transit times and total residence time for T,. Values are means ± S.E.M. 
NID-C MID-C NID-P MID-P 
Transit time, min 
Plasma 
Fast pool 
Slow pool 
Total residence time, min 
0.67 ± 0.01 
4.99 ± 0.36 
114± 15 
607 ± 76 
P<0.05: Pvs. C;eMIDvs. NID. 
0.76 ± 0.22 
6.64 ±1.35 
122 ± 25 
544 ± 95 
0.57 ± 0.04 
4.78 ± 0.66 
95 ±10 
513 ±52 
0.93 ±0.16® 
7.23 ±1.22 
99 ±23 
553 ± 94 
Enzymes 
Figure 2 shows the a-GPD activity in liver and brain. The same pattern is found for 
liver (2a) and brain (2b). The a-GPD activity decreased in the pregnant groups; 
marginal iodine deficiency had no effect. 
In the fetal liver and brain no differences in a-GPD activity were found between the 
NID and MID rats (data not shown). 
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Figure 2: a-GPD in maternal liver (A) and maternal brain (B). 
Values are means ± SEM. P < 0.05; * P vs. C. 
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The data on ME are shown in Fig.3. No effect of pregnancy or marginal iodine 
deficiency was found in the liver. In the brain however, ME activity increased in 
pregnant rats. 
Pregnancy and marginal iodine deficiency both increase ID-I activity in the liver 
(Fig.4); this increase is additive. 
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Figure 3: Malic enzyme in maternal liver (A) and maternal brain (B). 
Values are means ± SEM. P < 0.05; * P vs. C. 
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Figure 4: Deiodinase type I in liver. Values are means ± SEM. 
P < 0.05; * P vs. C, * MID vs. NID. 
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DISCUSSION 
The aim of this study was to determine whether a marginal iodine deficiency will 
affect thyroid hormone production, distribution, and transport in nonpregnant as well 
as near-term pregnant rats. During fetal growth thyroid hormones are necessary for 
development of the central nervous system. It has been shown that a moderately low 
iodine supply is sufficient for the daily needs of healthy adult subjects. During preg-
nancy, however, the iodine supply becomes relatively insufficient, due to enhanced 
maternal requirements (13) and increased renal clearance (1). 
Many animal studies have been performed to study the effect of iodine deficiency on 
the development of fetuses (9, 21), but no information is available on the effects of 
iodine deficiency on maternal thyroid hormone metabolism and the availability of 
maternal thyroid hormones during pregnancy. The effects of iodine deficiency on 
thyroid hormone secretion have only been described for nonpregnant rats (12, 23). 
In most experimental studies severe iodine deficiency was induced, while in our 
study the rats were marginally iodine-deficient. This condition is much more common 
in iodine-deficient areas. 
Severe iodine deficiency is characterized by an increase in thyroid weight, low 
serum T4, normal or slightly elevated serum T3 and high TSH (9, 22, 26). During 
pregnancy decreased reproductive competence has been reported (9). In our 
laboratory, rats receiving the same treatment as described for this study showed an 
increase in thyroid weight (30). Neither retarded growth nor decreased number of 
fetuses was observed, so the iodine deficiency achieved must have been marginal. 
During marginal iodine deficiency plasma T4 and T3 values remained unchanged, but 
plasma TSH increased sligthly. Even under these moderate conditions T4 and T3 
production and their plasma clearance rates had already changed. The kinetic 
experiment revealed a decreased production of T4 in nonpregnant MID rats. The 
unaltered plasma T4 might possibly be explained by the decreased plasma clearance 
rate, resulting in an increased mean residence time for T4 in the body. 
The production of T3 increased, but plasma T3 was not affected by marginal iodine 
deficiency. We attribute this to the increased plasma clearance rate. 
Janssen et al. (17) found no effect of iodine deficiency on hepatic ID-I activity, even 
though T4 in their animals was lower. In the brain an increase in ID-I I was found in 
iodine-deficient rats (17). In our study marginal iodine deficiency induced an in-
crease in hepatic ID-I activity. Therefore, the increased T3 production might possibly 
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be explained by enhanced T4 to T3 conversion in the liver. 
We suggest that rats are able to maintain their euthyroid status during marginal 
iodine deficiency. The alterations in T4 and T3 production are compensated by 
changes in the plasma clearance rates, resulting in normal thyroid hormone values 
in plasma and tissues. This is confirmed by the unchanged levels of the thyroid 
hormone-sensitive enzymes a-GPD and malic enzyme in liver and brain. 
The alterations in thyroid hormone metabolism due to pregnancy are in agreement 
with previous findings for iodine-sufficient rats (29). There is a difference in the 
effects of marginal iodine deficiency on the production and metabolism of T4 during 
pregnancy and in the nonpregnant situation. 
During pregnancy T4 production also decreased as a result of marginal iodine defi-
ciency, but the plasma clearance rate remained unchanged. This resulted in a 
decrease in the total amount of T4 in the body. Striking is the effect of marginal 
iodine deficiency on the transport of T4 to the fast pool in pregnant rats. During 
normal pregnancy the transport of T4 to the fast pool and vice versa is markedly 
increased. We suggested that this is caused by the fetal compartment (29). How-
ever, in marginally iodine-deficient near-term pregnant rats no increase in transport 
to the fast pool was found. This could indicate that during marginal iodine deficiency 
the transport of T4 to the fetal compartment is already diminished. This is exceeding-
ly important, because it is mainly T4 that is transported from mother to fetuses. The 
absence of maternal T4 during fetal development can cause damage to the central 
nervous system (4). However, we did not find any effect on a-GPD activity in the 
fetal brain during marginal iodine deficiency. This might possibly be explained by an 
increase in fetal ID-II; during severe iodine deficiency the fetal brain is protected 
from hypothyroidism by an increase in the activity of ID-II (21 ). 
The alterations in T3 metabolism due to marginal iodine deficiency found in pregnant 
rats are the exact opposite of the effects in nonpregnant rats. During pregnancy 
production and the plasma clearance rate of T3 decrease slightly; these parameters 
increase in nonpregnant rats. 
Despite a decrease in plasma T4 and T3 hepatic ID-I is increased at the end of 
gestation. This had already been described earlier (5, 29). Just as in nonpregnant 
rats a further increase of ID-I is found during marginal iodine deficiency. 
The transport of T3 from plasma to the fast pool and vice versa was decreased by 
fifty percent in marginally iodine-deficient pregnant rats. This implies that, despite 
the markedly increased ID-I activity, locally produced T3 is either decreased or does 
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not enter the circulation. 
The present results demonstrate that under these conditions marginal iodine intake 
influences maternal thyroid hormone metabolism. The total amount of T4 in the 
mother is decreased and less T4 is transported to the fetuses. So, even a marginal 
iodine deficiency seems to affect the availability of maternal T4 for the fetuses. 
Eventually this will cause fetal hypothyroidism, resulting in impaired fetal brain 
development. 
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CHAPTER 6 
MATERNAL THYROXINE AND 3,5,3'TRIIODOTHYRONINE KINETICS IN 
NEAR-TERM PREGNANT RATS AT TWO DIFFERENT LEVELS OF 
HYPOTHYROIDISM. 
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ABSTRACT 
Thyroid hormones are extremely important for development of the fetal central 
nervous system. Thyroidectomy results in severe hypothyroidism. In this study two 
levels of maternal hypothyroidism were reached by administration of different 
amounts of thyroxine (T4) and 3,5,3'-triiodothyronine (T3) to thyroidectomized preg-
nant rats. We examined the production, distribution and transport of T4 and T3 by 
performing a kinetic experiment (three-compartment analysis) with intact and thyr-
oidectomized near-term pregnant rats which received either very low (Tx+lowTH) or 
normal (Tx+TH) doses of T4 and T3. Despite administration of normal doses of 
thyroid hormones plasma TSH was still elevated in the Tx+TH rats, meaning that 
these rats were still mildly hypothyroid. The Tx+lowTH rats were markedly hypo-
thyroid, the plasma T4 and T3 levels being very low. In the mildly hypothyroid rats the 
transport of T4 from plasma to the fast pool and vice versa was decreased compared 
with intact near-term pregnant rats. This could imply that much less T4 is transported 
to the feto-placental compartment. Liver type I deiodinase was decreased, resulting 
in lowered plasma T3 values. In the markedly hypothyroid rats all pools and rates of 
transport of T4 and T3 were greatly decreased. In conclusion, even mild hypothyr-
oidism, despite normal plasma T4 values, results in significant changes, especially in 
maternal T4 transport. We suggest that even mild maternal hypothyroidism will have 
a negative effect on the availability of maternal T4 for fetuses. 
INTRODUCTION 
Thyroid hormones are extremely important for fetal development, especially of the 
central nervous system. In man, the children of mothers who were hypothyroid 
during pregnancy show a high incidence of behavioral and neurological disorders 
(14). 
Rat studies have demonstrated that maternal hypothyroidism during pregnancy has 
irreversible effects on brain development, as indicated by a decrease in the activity 
of various cell marker enzymes in the brain of the progeny (8). The influence of 
maternal hypothyroidism on fetal development is particularly dramatic during the first 
half of the gestational period (2). However, even after the fetal thyroid starts to 
function, on day 17.5-18 of gestation, maternal thyroid hormones contribute to the 
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fetal iodothyronine pool (16). The effects of maternal thyroidectomy, resulting in 
severe hypothyroidism, on fetal development and thyroid hormone levels have been 
studied extensively by the Madrid group (17, 19, 22). They demonstrated a decrease 
in the number of fetuses and the fetal body weight of thyroidectomized dams (17, 19, 
22). Maternal plasma thyroxine (T4) and 3,5,3'-triiodothyronine (T3) levels decreased 
markedly, while thyrotropin (TSH) was highly elevated in thyroidectomized rats. T4 
and T3 concentrations were decreased in both liver and brain tissue (17, 18, 20). 
The concentrations of T4 and T3 in embryonic tissues from thyroidectomized dams 
were undetectable before the onset of fetal thyroid function (19). At the end of 
gestation, on day 21, fetal plasma TSH was elevated (2) and the plasma T4 and T3 
levels of the fetuses of thyroidectomized dams were similar (22) or even slightly 
elevated (17, 20) compared to those of intact dams. Total thyroidal T4 and T3 levels 
in fetuses from thyroidectomized dams had decreased markedly by the end of gesta-
tion (22). The fetal liver T4 concentration was decreased, whereas such a change 
was not found for hepatic T3. The deiodinase type I (ID-I) activity in fetal liver had 
decreased by 50% (22). No effect of maternal thyroidectomy on T4 and T3 concentra-
tions in fetal brain on day 20 was found; in contrast, an increase in the cerebral T4 
and T3 concentrations on day 21 was reported (17, 19). 
Euthyroidism can be restored in thyroidectomized rats by administration of both T4 
and T3 (6). If the amount of thyroid hormones administrated is less than the amount 
normally produced, the animal will still be hypothyroid. In the present study two 
levels of thyroid hormone status were achieved by the administration of different 
amounts of T4 and T3 to thyroidectomized pregnant rats. 
The aim of our study was to examine the effects of a mild and a marked hypothyroid 
state on maternal thyroid hormone metabolism in the near-term pregnant rat. T4 and 
T3 metabolism, distribution, and transport were examined by performing kinetic 
studies using the three-compartmental model of distribution and metabolism de-
veloped by DiStefano (3, 4). In this model three compartments can be distinguished: 
1 ) the plasma; 2) tissues that exchange T4 and T3 with plasma at a fast rate, the fast 
pool; and 3) tissues which exchange at a slow rate, the slow pool. Liver and kidney 
are considered to be the main components of the fast pool, whereas skin, muscle 
and brain belong to the slow pool (3, 4). Previously we suggested that in normal 
near-term pregnant rats T4 is transported very rapidly from plasma to the feto-pla-
cental compartment (25). In the present study we compared the transport of maternal 
thyroid hormones to the feto-placental compartment during different levels of hypo-
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thyroidism. The mildly hypothyroid rats are of special interest; will there already be 
an effect on maternal thyroid hormone metabolism, and is the maternal contribution 
of thyroid hormones to the fetal compartment affected ? 
MATERIAL AND METHODS 
Animals and diet 
Female Wistar rats (CPB/WU, Iffa Credo, Brussels) weighing 150 g were rendered 
hypothyroid by means of 131l thyroid ablation (a single intraperitoneal injection of 15 
Mbq (0.4 mCi) Na131l). One week before and one week after radiothyroidectomy the 
rats received iodide-free American Institute of Nutrition (AIN) food (1). Subsequently 
iodide-rich AIN food (40 ug Kl per g food) was given for 5 days to wash the 131l out of 
the animals' system. During the rest of the experiment the animals received AIN food 
(dry powder mixed with distilled water (60% dry weight - 40 % water)) containing 55 
ng iodide/g food. 
Intact, age-matched controls also consumed AIN food with 55 ng iodide/g food. 
Hypothyroidism was demonstrated by undetectable plasma T4 levels six weeks after 
radiation. No sooner than two months after radiothyroidectomy the rats were mated. 
Until mating the rats received 0.25 ug T3 daily. Mating was confirmed by the pres-
ence of sperm in a vaginal lavage the following morning, called day 0 of gestation. 
Design of the study 
Three groups of rats were used: 
1. Intact: intact, pregnant euthyroid rats. 
2. Tx+TH: pregnant radiothyroidectomized (Tx) rats on high T4 and T3 (0.25 ug T3 
and 2.5 ug T4 per day added to the AIN diet). 
3. Tx+low TH: pregnant radiothyroidectomized (Tx) rats on low T4 and T3 (0.01 ug 
T3 and 0.1 ug T4 per day added to the AIN diet). 
T4 and T3 were purchased from Sigma (St. Louis, MO, USA). 
Kinetic experiments were performed on day 19 of gestation. Twenty-four hours after 
the kinetic experiment the animals were killed; maternal blood, liver, brain and 
pituitary were collected. 
The experiments were approved by the University Committee on Animal Care and 
Use of the Agricultural University of Wageningen. 
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Kinetic and analytical protocols 
[125I]T4 and [131I]T3 (specific activity 80 and 130 Mbq/|jg (2200 and 3500 (uCi/ug), 
respectively) were prepared in our laboratory (11, 26). Na125l and Na131l were ob-
tained from Amersham (Arlington Heights, IL, USA); L-T3 and 3,5-L-diiodothyranine, 
the respective substrates for labelling, were purchased from Sigma (St. Louis, MO, 
USA). Purity of the tracers was assessed by means of HPLC. 
Via a cannula inserted into the right jugular vein (21) the rats received a 400 pi 
bolus injection of a solution of 3700 Bq (10 uCi) [125I]T4 and 3700 Bq (10 uCi) [131I]T3 
in saline containing heparin (0.3 U/ml; Organon, Tilburg, The Netherlands), ticarcillin 
(0.4 mg/ml; Ticarpen, Beecham S.A., Heppignies, Belgium) and 5% normal rat 
serum. Ticarcillin is added to solutions containing labelled iodothyronines to prevent 
eventual bacterial infections and reduce artefactual deiodination, as described by 
Van Doorn et al. (5). 
Blood samples of 0.2 ml were taken at 1, 4.5, 10, 23, 44, 115, 202 and 315 min; 0.4 
ml. were drawn at 465, 600, 900, 1200 and 1440 min, being the optimal time schedu-
le according to DiStefano ef al. (3, 4). 
Fifty to hundred microliters plasma (in duplicate) were used to assess the total 131l 
and 125l activities. The plasma samples were extracted with ethanol/ammonia 
(25%)(197:3 v/v) containing 0.1 mmol/l propylthiouracil (PTU). The dried extracts 
were dissolved in 0.1 ml 0.2 mol/l ammonia containing carrier T4, T3 and Kl (1 mg/10 
ml) and subjected to HPLC to separate the iodothyronines, according to the method 
described by Schröder-van der Eist and van der Heide (23). 
The endogenous concentrations of T4 and T3 in plasma were measured by means of 
a specific rat RIA (9) of samples taken via the canula directly before the kinetic 
experiments were performed. 
Plasma TSH was measured by the specific RIA developed for the rat by the National 
Institute of Diabetes and Digestive and Kidney Diseases of the National Institute of 
Health (USA). Reference preparation RP-2 was used as a standard. 
Calculations 
The percentage doses of [131I]T3 and [12SI]T4 per ml plasma were calculated from the 
total radioactivities and the [131I]T3 and [125I]T4 distributions on the HPLC chromato-
gram. The percentage doses per ml, together with the plasma volume at t(0) (3), 
were fitted individually to sums of n=1 to 3 exponential. 
Y(t)= A1 exp(\1*t) + A2 exp(A2*t) + A3 exp(A3*t) 
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using the program DIMSUM, whereby Ai is expressed in %dose/ml, Äi in min"1 (15). 
To calculate the parameters of production, distribution and metabolism the program 
MAMPOOL (12) was used. The sum of the three exponential functions was fitted (by 
weighted least squares regression analysis) to the data collected for each individual 
rat and, together with the plasma T4 and T3 levels, substituted into the three-com-
partment model, according to the kinetic T4 and T3 studies of DiStefano et al. (3, 4). 
All data are expressed as means ± S.E.M. Data were analyzed using the Statistical 
Package for Social Sciences (SPSS)(24). All data were subjected to one-way ana-
lysis of variance, and statistical differences between groups were determined by 
means of the modified least significant difference method. 
Analytical determinations 
Mitochondrial fractions from liver and brain were obtained by differential centrifu-
gation, according to the separation scheme described by van Doom (5). 
Liver and brain mitochondrial alpha-glycerophosphate dehydrogenase (a-GPD; EC 
1.1.2.1) was measured by means of the method described by Garrib and Mc Murray 
(7). 
The determination of type I deiodinase (ID-I) activity in liver homogenates was 
performed by the method described by Janssen et al. (10). 
Protein was determined by the bicinchoninic acid (BCA) method (Pierce Europe, 
Oud Beijerland, the Netherlands) using bovine serum albumin as standard. 
RESULTS 
Body weight and plasma hormones 
Table 1 shows the body weight (BW) and plasma thyroid hormone levels. At the start 
of pregnancy all rats had a similar BW. Hypothyroidism affects the BW of the near-
term pregnant rat. Tx+lowTH rats had a significantly lower BW. The BW of the 
fetuses of Tx+lowTH mothers was also decreased. In this group the number of viable 
fetuses was decreased, while more dead and resorbed fetuses were found. 
Plasma T4 is markedly decreased in the Tx+lowTH group, while in the Tx+TH group 
a normal T4 level was reached. 
Plasma T3 is decreased in both Tx groups; no difference was found between the 
Tx+lowTH and Tx+TH groups. 
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Plasma TSH was highly elevated in both Tx groups. In Tx+lowTH rats the plasma 
TSH level was higher than in Tx+TH rats. 
Table 1 : Body weight and plasma thyroid hormone concentrations in the intact, Tx+TH and 
Tx+lowTH groups. Values are means ± S.E.M. 
Body wt on day 0 (g) 
Body wt on day 19 (g) 
No. of fetuses 
Fetal body wt (g) 
T4 (nmol/l) 
T3 (nmol/l) 
TSH (ng/ml) 
Intact group 
(n=8) 
226 ±3 
299 ±7 
11 ±1 
4.24 ± 0.07 
23.6 ±1.6 
0.50 ± 0.06 
0.56 ±0.08 
Tx+TH group 
(n=7) 
229 ±4 
300 ±3 
9 ± 1 
4.14 ±0.06 
30.6 ± 3.1 
0.28 ± 0.05 e 
4.57 ±0.61® 
Tx+lowTH group 
(1=8) 
228 ±5 
252 ±5* " 
7 ± 2 
3.38 ±0.19** 
4.0 ±0.9** 
0.21 ±0.01* 
7.83 ±0.32** 
P < 0.05: ® Tx+TH vs. Intact, * Tx+lowTH vs. Intact, * Tx+lowTH vs. Tx+TH 
TA kinetics 
The disappearance curves for T4, based on the mean A and K values for the three 
groups, are shown in Fig. 1. The slope of the regression lines for plasma is de-
creased in Tx+lowTH rats, meaning that T4 disappeared from plasma more slowly in 
this group. The fractional turnover rates for all three pools were decreased (data not 
shown). As a result the transport between plasma and the fast pool in Tx+TH rats 
was 10 % of that for intact controls and only 1% in the Tx+lowTH group. 
For T4, distribution volumes, pool sizes, and transport rates are summarized in Table 
2. The plasma clearance rate was decreased in both Tx groups, but no additional 
decrease was found for Tx+lowTH rats. The calculated rate of production of T4 in the 
Tx+TH group was similar to that found for intact rats. The low T4 production' in the 
Tx+lowTH group resulted in an equivalent decrease in the amount of T4 in all three 
pools. The distribution volumes of T4 remained unchanged. 
The rate of transport of T4 from plasma to the fast pool and vice versa was markedly 
decreased in both Tx groups, an additional decrease was found for Tx+lowTH rats. 
The transport of T4 between plasma and the slow pool was only decreased in the 
Tx+lowTH group. It also appeared that in these rats an increasing fraction of T4 was 
transported unidirectionally from plasma to the slow tissue pool. 
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The transit times in all three pools are increased in both Tx groups, but no significant 
change in the total residence time was found (results not shown). 
Table 2: Parameters of distribution, volumes, pool sizes, and rates of transport of T4 (expres-
sed per 100 g body weight) in the intact, Tx+TH and TX+lowTH groups. Values are means ± 
S.E.M. 
PCR (ml/h) 
PR (pmol/h) 
Vtotal (ml) 
Vp (ml) 
V2 (ml) 
V3 (ml) 
Qtotal (pmol) 
Qp (pmol) 
Q2 (pmol) 
Q3 (pmol) 
TRpf (pmol/h) 
TRfp (pmol/h) 
DRfo (pmol/h) 
TRps (pmol/h) 
TRsp (pmol/h) 
DRso (pmol/h) 
%PF 
%PS 
Intact group 
1.64 ±0.04 
38.5 ±2.5 
17.6 ±1.0 
4.9 ±0.1 
3.8 ±0.4 
8.9 ± 0.6 
437 ± 32 
116±6 
88 ±9 
207 ±17 
2542 ± 390 
2523 ± 389 
19.3 ±1.2 
195 ±36 
176 ±35 
19.3 ±1.2 
92.9 ± 0.8 
7.1 ±0.8 
Tx+TH group 
1.19 ± 0.07e 
35.6 ± 2.7 
16.6 ±0.8 
5.0 ±0.1 
3.8 ±0.7 
7.8 ±0.3 
519 ±78 
156 ±20 
122 ± 33 
239 ± 30 
794 ±177® 
776 ±177® 
17.8 ±1.3 
143 ± 43 
125 ± 43 
17.8 ±1.3 
85.0 ± 2.3 
15.0 ±2.3 
Tx+lowTH group 
1.26 ±0.09* 
4.7 ±1.0** 
17.4 ±2.4 
4.8 ±0.2 
2.4 ±0.5 
10.2 ±2.6 
64 ±14** 
19 ±5** 
9±3 * # 
36 ±9** 
33 ±8* 
31 ±8* 
2.4 ±0.5** 
16 ±4** 
13 ±4* 
2.4 ±0.5** 
67.2 ±10.0* 
32.8 ± 10.0* 
PCR, plasma clearance rate; PR, production rate; V, plasma equivalent distribution volume; 
Q, pool quantity; TRpf, TRfp, TRps, and TRsp, rates of transport between plasma and the fast 
and slow pools respectively, in each direction; DRfo and DRso, disposal rate from fast and 
slow pool respectively; % PF and %PS, fraction of T4 in plasma transported unidirectionally to 
the fast and slow tissue pools respectively; p, plasma; 2, fast pool; 3, slow pool. 
P < 0.05: e Tx+TH vs. Intact, * Tx+lowTH vs. Intact, * Tx+lowTH vs. Tx+TH. 
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Figure 1 : 
T4-disappearance curves obtained with 
a three exponential model. 
(A) plot of log y(t) (in % dose/ml) 
against time, with the least squares 
regression line on the final straight 
part of the curve, giving estimates of 
coefficient A3and exponent K3. 
(B) plot of log [y(t) - A3 exp(A3*t)] 
against time, with the least squares 
regression line on the curve, giving 
estimates of coefficient A2 and expo-
nent A2. 
(C) plot of log [y(t) - A3 exp(A3*t) - A2 
exp(A2*t)] against time, giving estim-
ates of coefficient A, and exponent A,. 
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T3 kinetics 
The kinetic parameters for T3 are significantly different from intact rats only in the 
Tx+lowTH group. The fractional rate of turnover of T3 in plasma and the transport 
rates from plasma to the tissue pools were decreased (data not shown). 
Most changes found in the distribution, metabolism and transport of T3 (Table 3) 
were similar for the Tx+TH and Tx+lowTH groups. The plasma clearance rate for T3 
was decreased. The plasma appearance rate and the production rate for T3 were 
diminished in all Tx rats. 
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Table 3: Parameters of distribution, volumes, pool sizes, and rates of transport of T3 
(expressed per 100 g body weight) in the intact, Tx+TH and TX+lowTH groups. Values are 
means ± S.E.M. 
PCR (ml/h) 
PAR (pmol/h) 
PR (pmol/h) 
Vtotal (ml) 
Vp (ml) 
V2 (ml) 
V3 (ml) 
Qtotal (pmol) 
Qp (pmol) 
Q2 (pmol) 
Q3 (pmol) 
TRpf (pmol/h) 
TRfp (pmol/h) 
DRfo (pmol/h) 
TRps (pmol/h) 
TRsp (pmol/h) 
DRso (pmol/h) 
% P F 
% P S 
Intact group 
25.0 ±2.4 
12.2 ±1.2 
13.5 ±1.1 
201 ± 2 0 
4.8 ±0 .1 
28.3 ±3.0 
200 ± 37 
115 ± 19 
2.4 ±0.3 
13.8 ±1.3 
99 ± 1 9 
205 ± 27 
199 ± 2 7 
6.1 ±0.6 
53.3 ±13.4 
54.9 ±13.8 
7.4 ±0 .6 
80.5 ± 3.4 
19.5 ±3 .4 
Tx+TH group 
17.6 ±1.3® 
4.9 ± 0.9e 
5.5 ±1.0® 
173 ± 1 3 
5.4 ±0 .6 
28.1 ±2.7 
139 ±11 
49 ±9® 
1.5 ±0.2® 
7.9 ±1.3® 
44 ± 12® 
115 ± 21® 
112 ±20® 
2.5 ±0.5® 
16.5 ±2.6® 
16.9 ±2.7® 
3.0 ± 0.6® 
86.7 ±1.5 
13.3 ±1 .5 
Tx+lowTH group 
16.8 ±1.9* 
3.6 ± 0.5* 
4.2 ±0.8* 
138 ± 7 * 
5.6 ± 0.5* 
17.3 ±1 .3 * * 
115 ± 7 * 
29 ± 2 * 
1.1 ± 0 . 1 * 
3.6 ±0 .3* * 
24 ± 2 * 
50 ± 6 * 
48 ± 6 * 
1.8 ±0.3* 
10.3 ± 0.8* 
10.6 ±0.9* 
2.5 ± 0.5* 
81.8 ±2.2 
18.2 ±2 .2 
PCR, plasma clearance rate; PAR, plasma appearance rate; PR, production rate; V, plasma 
equivalent distribution volume; Q, pool quantity; TRpf, TRfp, TRps, and TRsp, rates of trans-
port between plasma and the fast and slow pools respectively, in each direction; DRfo and 
DRso, disposal rate from fast and slow pool respectively; % PF and %PS, fraction of T3 in 
plasma transported unidirectionally to the fast and slow tissue pools respectively; p, plasma; 
2, fast pool; 3, slow pool. 
P < 0.05: ® Tx+TH vs. Intact, * Tx+lowTH vs. Intact, * Tx+lowTH vs. Tx+TH. 
The total distribution volume as well as the distribution volume of the tissue pools 
was reduced in the Tx+lowTH group only. In all pools the amount of T3 had decrea-
sed in both Tx groups. The transport of T3 in all directions was reduced. 
No significant changes, except an increase in the transit time for plasma (0.6±0.06 
min and 1.2±0.15 min for intact and Tx+lowTH rats respectively), were found for the 
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transit times and the total residence time of T3. 
Enzyme activities 
The a-GPD activities in liver and brain are shown in Fig. 2. Hepatic a-GPD activity 
was reduced in the Tx+TH group; an even stronger decrease was found for the 
Tx+lowTH group. No effect of hypothyroidism on a-GPD activity in the brain could be 
demonstrated. 
Deiodinase type I (ID-I) activity (in mOD/min/mg protein) was diminished in all Tx 
rats; 267±13, 147±16, and 73±8 for intact, Tx+TH and Tx+lowTH rats respectively. 
Thus the strongest reduction was found in the Tx+lowTH rats. 
a-GPD in liver a-GPD in brain 
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Figure 2: a-GPD in maternal liver and maternal brain in the three groups studied (intact, 
Tx+TH, Tx+lowTH). P< 0.05; sTx+TH vs. intact; * Tx+lowTH vs. intact; *Tx+lowTH vs. Tx+TH. 
DISCUSSION 
Thyroidectomy resulted in a lower increase in bodyweight during pregnancy. This is 
due not only to the diminished weight of the mother but also to reduction of the fetal 
compartment. Treatment of the Tx animals with T4 and T3 (Tx+TH) normalized the 
bodyweights of mother and fetus. 
Since the plasma thyroid hormone and TSH levels are not normal, the Tx+TH group 
is certainly not euthyroid; we describe them as mildly hypothyroid. Tx animals which 
received a very low dose of T4 and T3 (Tx+lowTH) were markedly hypothyroid, the 
levels of plasma T4 and T3 being very low. 
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Hypothyroidism is known to influence thyroid hormone metabolism. In this study we 
concentrated on the effects of hypothyroidism on maternal thyroid hormone metabo-
lism. The most important information about the effects of hypothyroidism on the 
availability of maternal thyroid hormones for fetuses will be obtained from the mildly 
hypothyroid group; does this state already have an effect on maternal-fetal trans-
port? 
Despite normal plasma T4 values in the mildly hypothyroid group the transport of T4 
from plasma to the fast pool, compared to intact near-term pregnant rats, was al-
ready strongly reduced; in markedly hypothyroid rats almost no T4 was transported 
to the fast pool. Previously we suggested that in pregnant rats the fast pool consists 
of the liver, the kidney (3, 4), and the feto-placental compartment. In intact rats 
pregnancy results in a pronounced increase in the transport of T4 from plasma to the 
fast pool (25). 
It is unlikely that the total decrease in the transport of T4 to the fast pool in mildly 
hypothyroid rats can be explained solely by a decrease in the transport of T4 to the 
liver and kidney. This implies, therefore, that even in a mildly hypothyroid situation 
the transport of maternal T4 to the placenta can also be diminished. This is very 
important, because T4 plays a major role in the development of the fetal central 
nervous system. Only maternal T4 is able to mitigate fetal cerebral T4 and T3 defi-
ciency before the fetal thyroid starts to function (18). 
The plasma T3 level in the mildly hypothyroid group was not normal. The amount of 
T3 added was less than the amount of T3 produced daily in intact rats (0.25 ug vs. 
0.60 ug per day). However, since the plasma T4 level was normal, it was to be 
expected that T3 would also be produced locally. T3 produced locally in the liver 
contributes in particular to the plasma T3 level (5). However, in the hypothyroid rat 
the local production of T3 is decreased in the liver (5). This was also demonstrated 
by the decrease in ID-I activity in the liver; this can possibly be explained by the 
regulation of hepatic ID-I activity by T3 (13). Therefore, even in a mildly hypothyroid 
condition with normal plasma T4 levels, the T3 level in the liver will be reduced; this 
hypothesis is supported by the decrease in hepatic a-GPD activity. 
For non-pregnant thyroidectomized rats receiving an infusion of T4 and T3 it has 
been reported that in the event of normal plasma T4 levels and a reduced plasma T3, 
hepatic ID-I and cerebral ID-II activities will be normal (6). However, despite the 
administration of T4 in an amount which equals the amount normally produced, local 
T3 production was decreased in our near-term pregnant rats. It appears, therefore, 
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that in near-term pregnant rats the effect of mild hypothyroidism is stronger than in 
non-pregnant rats. 
Marked hypothyroidism in both non-pregnant and near-term pregnant rats results in 
highly reduced pools and diminished rates of transport of T4 and T3. 
In conclusion, even mild hypothyroidism results in significant alterations in maternal 
thyroid hormone metabolism, despite normal plasma T4 levels. In particular the 
transport of T4 from plasma to the fast pool will be reduced. We speculate that this 
results in a decrease in the availability of maternal T4 for the fetuses. This could 
affect the development of the fetal brain, which depends mainly on maternal T4 for 
normal T3 values. 
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GENERAL DISCUSSION AND CONCLUSION 
Thyroid hormone metabolism is influenced by several (patho)physiological condi-
tions. During pregnancy thyroid hormone metabolism is also altered. The aim of this 
study was to investigate the effects of pregnancy on maternal thyroid hormone 
metabolism, i.e. - T4 and T3 secretion by the thyroid 
- peripheral production of T3 
- T4 and T3 concentrations in plasma and tissues 
- distribution of T4 and T3 
- interpool transport of T4 and T3 
Since iodine is an essential element of the synthesis of thyroid hormones we also 
studied changes in iodide uptake by the thyroid during normal pregnancy and during 
marginal iodine deficiency. 
7.1. NORMAL PREGNANCY 
Iodide uptake by the thyroid is regulated by TSH. In the near-term pregnant rat the 
plasma TSH level remains unchanged or is slightly elevated (3, 4, 6). During preg-
nancy the iodide uptake, which is slightly decreased, does not seem to be regulated 
by TSH only. Another factor which affects iodide uptake by the thyroid is the thyr-
oidal blood flow (1 ). We did not measure this parameter, but no changes were found 
in either the clearance of iodide from plasma by the thyroid or plasma inorganic 
iodide. We suggest that less iodide is taken up by the maternal thyroid simply be-
cause less iodide is available: at the end of gestation the mother has to compete 
with the fetuses for her iodine supply. Iodine can be transported through the pla-
centa from mother to fetuses (7); on day 19 of gestation the fetal thyroid is capable 
of concentrating iodine. The decreased availability of iodide for the maternal thyroid 
is not so dramatic that thyroid hormone production by the thyroid is affected. The 
thyroid is still able to maintain thyroid hormone synthesis at a normal level. 
Despite the unaltered thyroidal production of T4, the plasma T4 concentration is 
decreased at the end of gestation which demonstrates that altered plasma concen-
trations are not always the result of changes in production rate. In the pregnant rat 
the transport of T4 from plasma increases drastically. Most likely T4 is also trans-
ported to the feto-placental compartment, which is a developing compartment that 
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must be filled at the end of gestation. With the three-compartment model it is not 
possible to distinguish between maternal tissues and the feto-placental compart-
ment. Therefore, we could only speculate about changes in transport to the feto-
placental compartment in our kinetic studies. However, for the normal pregnant rat 
we also have data from steady-state experiments. These data show that the tissue-
to-plasma ratio for T4 decreased in all maternal tissues in the near-term pregnant rat. 
Since plasma T4 decreased, the amount of T4 in the tissues diminished even more. 
In the kinetic study the amount of T4 in the tissue pools of near-term pregnant rats 
remained constant. This implies that one part of the tissue pools consists of non-
maternal organs, i.e. placentas plus fetuses. Therefore, despite a normal thyroidal 
production less T4 is available for the maternal organs which results in decreased 
tissue T4 concentrations, as well as a decrease in the tissue T3 concentration in most 
organs. Even an increase in deiodinase activity, ID-I as well as ID-II (3), would not 
lead to normal tissue T3 levels, as has been demonstrated by the steady-state 
experiments. 
7.2. MARGINAL IODINE DEFICIENCY DURING PREGNANCY 
In the normal situation the mother shares the available iodide and T4 with her fe-
tuses, at the cost of her own supply. However, during marginal iodine deficiency 
(MID) the amount of available iodide is reduced. By means of an increase in thyr-
oidal clearance, resulting from an increase in thyroid volume and thyroidal blood flow 
(1), the mother is able to maintain a normal absolute iodide uptake by the thyroid. 
Just as during normal pregnancy these processes do not seem to be regulated by 
TSH, because plasma TSH remains unchanged. In the fetuses the absolute iodide 
uptake is decreased during MID; the fetal thyroid is not able to compensate for the 
decrease in plasma inorganic iodide. This can possibly result in a diminished thyroid 
hormone production by the fetal thyroid. During maternal hypothyroidism fetal plas-
ma TSH is elevated (2). However, the effect of MID on fetal TSH is unknown. 
Both the production of T4 by the maternal thyroid and the amount of T4 in plasma and 
the tissue pools are only slightly decreased in the near-term pregnant rat. The 
mother is able to maintain the euthyroid state during MID. Therefore, it appears that 
MID will not affect the availability of T4 for the fetuses. However, the transport of T4 is 
seriously altered during MID. In particular interpool transport between plasma and 
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the fast pool is decreased. This could mean that less T4 is transported to the fetuses. 
Since data on fetal thyroid hormones are not available it is difficult to speculate on 
the consequences for fetal development. The fetal brain is able to avoid T3 defi-
ciency by increasing ID-II activity (6). However, if there is insufficient substrate, i.e. 
T4, this will not result in normal T3 levels. This might be the situation during MID, 
because both the maternal and fetal supplies of T4 are decreased. 
7.3. MATERNAL HYPOTHYROIDISM 
During maternal hypothyroidism only the maternal thyroid function is affected. The 
availability of iodide for the fetuses is normal or perhaps even increased. We have 
described a moderate situation, meaning that T4 and T3 are available, but normal 
plasma concentrations had not yet been reached; plasma T4 was normal, whereas 
plasma T3 was decreased. Despite the normal plasma T4, the transport of T4 to the 
fast pool, including the feto-placental compartment, was reduced to 30 % of that 
found for intact animals. This means that even in a mild hypothyroid state the avail-
ability of maternal T4 for the fetuses is diminished. 
7.4. IN CONCLUSION 
During normal pregnancy the production of T4 by the thyroid remains unchanged. 
However, this T4 has to be distributed between the mother and her fetuses. This 
results in a decreased availability of T4 for the maternal organs, leading indirectly to 
a deficiency of T3 in the maternal organs. 
During marginal iodine deficiency and maternal hypothyroidism the mother maintains 
the same thyroidal status in all organs as during normal pregnancy. This occurs at 
the expense of the availability of iodide and T4 for the fetuses, which in the long run 
could lead to impaired development of the fetal central nervous system. 
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SUMMARY 
Thyroid hormones, thyroxine (T4) and 3,5,3'-triiodothyronine (T3), are produced by 
the thyroid gland. To synthesize thyroid hormones the thyroid needs iodide. The 
uptake of iodide as well as the production and secretion of T4 and T3 by the thyroid 
gland is regulated by thyrotropin (TSH), which is produced by the pituitary. However, 
most of the biologically active form, T3, is produced from T4 via monodeiodination in 
peripheral tissues. This reaction is catalyzed by the deiodinases, type I (ID-I) in liver 
and kidney, and type II (ID-II) in the central nervous system and brown adipose 
tissue (BAT). T4 and T3 concentrations differ in the various tissues, like the contribu-
tion of T3 produced locally from T4. A large portion of the T3 produced in the liver 
enters the circulation, whereas T3 produced in the brain and cerebellum is mainly 
used locally. 
The production, distribution and transport of thyroid hormones are influenced by 
several (patho)physiological conditions. In this study we concentrated on the effects 
of pregnancy on maternal thyroid hormone metabolism. It is well known that thyroid 
hormones are very important for normal fetal development, especially of the central 
nervous system. During development thyroid hormones produced by the mother, 
mainly T4, contribute to the fetal thyroid hormone pools before and also after onset of 
fetal thyroid function. Insufficient production of maternal thyroid hormones during 
pregnancy can result in permanent brain damage in the offspring. At the end of 
gestation the concentrations of T4 and T3 in maternal plasma and tissues have 
decreased. In order to gain more insight into the effects of pregnancy on the produc-
tion, distribution, and transport of thyroid hormones in the mother we performed 
kinetic experiments with T4 and T3 using nonpregnant and near-term pregnant rats 
(chapter 2). A bolus injection of [12SI]T4 and [131I]T3 was given, and blood samples 
were taken at regular times during the next twenty-four hours. Physiological para-
meters of the production, interpool transport, distribution and metabolism of T4 and 
T3 were estimated by means of a three-compartment model. According to this model 
three compartments can be distinguished: 1. the plasma; 2. the fast pool; and 3. the 
slow pool. Liver and kidney are considered to be the main components of the fast 
pool, whereas skin, muscles and brain belong to the slow pool. In the near-term 
pregnant rat the production and distribution of T4 remained unchanged. The trans-
port of T4 from plasma to the fast pool was more than tripled, whereas transport to 
the slow pool remained constant. We suggest that in the near-term pregnant rat 
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available T4 was distributed between the maternal and fetal compartments by means 
of very fast transport. This hypothesis is based on the fact that it seems unlikely that 
the transport of T4 to maternal liver and kidney, which are considered to be the main 
components of the fast pool, will have increased that much in the near-term pregnant 
rat. This was confirmed by the results of steady-state, double isotopic experiments 
using nonpregnant and near-term pregnant rats (chapter 3). In this study, the rats 
received a continuous simultaneous infusion of [12SI]T4 and [131I]T3 in order to achieve 
equilibrium in all tissues. With this method it was possible to calculate the T4 and T3 
concentrations, the relative contributions of plasma-derived vs. locally produced T3, 
the thyroidal T4 and T3 secretion rates, and the plasma-to-tissue ratios for T4 and T3. 
Indeed, the transport of T4 to liver and kidney, as well as almost all other maternal 
organs, was diminished. Since the production of T4 remained unchanged this implies 
that T4 is transported to another compartment, i.e. the feto-placental compartment. 
This compartment was not measured in these studies. The plasma appearance rate 
for T3 remained constant in the near-term pregnant rat. This was accomplished by an 
increase in the secretion of T3 by the thyroid and a decrease in locally produced T3. 
Less T3 was transported from plasma to liver, kidney, BAT and pituitary. ID-I activity 
in liver, and ID-II activity in the brain both increased during pregnancy. However, this 
did not result in an increase in the local conversion of T4 to T3 in these tissues. In the 
liver the contribution of T3 produced locally remained constant, while in the brain 
even a decrease was found. The insufficient availability of T4 in maternal tissues, as 
demonstrated by the lower T4 concentrations, might explain the discrepancy between 
deiodinase activities and the local production of T3. The transport of T4 to the feto-
placental compartment resulted indirectly in a deficiency of T3 in the maternal or-
gans. We can conclude that pregnancy affects maternal thyroid hormone metabol-
ism. The mother has to share the available thyroid hormones, especially T4, with the 
fetuses. 
Iodide is an essential element for the synthesis of thyroid hormones. In rats the fetal 
thyroid is capable of producing thyroid hormones on day 18 of gestation. Iodide is 
transported across the placenta from the maternal to the fetal circulation. In chapter 
4 we assessed iodide uptake by the maternal thyroid, while the iodide uptake by the 
fetal thyroid was estimated. We measured the in vivo uptake of 12SI by the thyroid 
continuously. By using the specific activity of iodide in the urine we were able to 
calculate the absolute iodide uptake in the thyroid. Pregnancy resulted in a decrease 
in the absolute thyroidal iodide uptake. On day 20 of pregnancy the fetal thyroid is 
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already capable of concentrating iodide. However, the difference in absolute iodide 
uptake by the maternal thyroid, compared to nonpregnant controls, cannot fully be 
explained by the transport of iodide to the fetal compartment and/or the mammary 
glands. The decrease in iodide uptake by the maternal thyroid has no impact on the 
thyroidal production of thyroid hormones. 
Iodine deficiency can lead to disturbed physical and mental development. In large 
populations in the world iodine intake is marginally deficient. For this reason a 
marginal iodine deficiency, instead of the more common severe iodine deficiency, 
was induced in our rats. We used this model to study the effects of marginal iodine 
deficiency on iodide metabolism (thyroidal iodide uptake; chapter 4) and thyroid 
hormone metabolism (kinetic experiments; chapter 5) in near-term pregnant rats. 
The absolute iodide uptake by the maternal thyroid was not affected by marginal 
iodine deficiency. The decreased plasma inorganic iodide was compensated by an 
increase in thyroidal clearance. A similar compensation was not found for the fetus; 
the uptake of iodide by the fetal thyroid decreased by 50 % during marginal iodine 
deficiency. During this marginal iodine deficiency plasma T4 and T3 remained con-
stant in nonpregnant as well as near-term pregnant rats. The production rate and the 
plasma clearance rate for T4 were both decreased. No effects of marginal iodine 
deficiency on pool sizes and transport rates were found for nonpregnant rats. In the 
near-term pregnant rat marginal iodine deficiency resulted in a marked decrease in 
the transport of T4 from plasma to the fast pool. For T3 an increase in the production 
rate and plasma clearance rate was found for nonpregnant, marginally iodine-
deficient rats, while these parameters were slightly decreased in near-term pregnant 
rats. Marginal iodine deficiency induced a 50 % decrease in the interpool transport 
rates of T3 between plasma and the fast pool in near-term pregnant rats. The hepatic 
activity of ID-I was increased as a result of marginal iodine deficiency in nonpreg-
nant as well as near-term pregnant rats. 
On the basis of the results of thyroid hormone studies in normal pregnant rats (chap-
ter 2 and 3) we suggest that during marginal iodine deficiency less maternal T4 is 
available for the fetal compartment. Together with the lower uptake of iodide by the 
fetal thyroid this can lead to diminished levels of thyroid hormone of maternal and 
fetal origin in the fetal organs. In this case, marginal iodine deficiency will have a 
negative effect on fetal development, especially of the brain. 
Another situation which irreversibly affects fetal brain development is maternal 
hypothyroidism. Two different levels of hypothyroidism were induced in female rats, 
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by giving thyroidectomized rats two different doses of T4 and T3. The effects of 
hypothyroidism on maternal thyroid hormone metabolism in near-term pregnant rats 
(kinetic experiment, chapter 6) were studied. Plasma T4 and T3 levels were very low 
severely hypothyroid animals, whereas only plasma T3 was decreased in the mildly 
hypothyroid group. Even during this mild hypothyroidism profound alterations in the 
transport rates of T4 were found compared to intact, pregnant rats. The transport of 
T4 from plasma to the fast pool was decreased. Therefore, it appears that even 
during mild hypothyroidism the transport of T4 to the feto-placental compartment is 
affected. 
In conclusion: Pregnancy seriously affects the maternal thyroid hormone status. 
Despite an unchanged thyroidal production of T4, all maternal T4 tissue levels are 
decreased. Less T4 is available for the mother because of the transport of T4 to the 
feto-placental compartment. Indirectly this results in a T3-deficiency in most maternal 
organs. During marginal iodine deficiency and maternal hypothyroidism the transport 
of maternal T4 to the feto-placental compartment is diminished, whereas during 
marginal iodine deficiency the availability of iodine for fetal thyroid hormone syn-
thesis is also decreased. Eventually this can result in impaired development of the 
fetal central nervous system. 
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SAMENVATTING 
Schildklierhormonen, thyroxine (T4) en 3,5,3'-triiodothyronine (T3), worden geprodu-
ceerd door de schildklier. Voor de vorming van schildklierhormoon heeft de schildklier 
Jodide nodig. Zowel de opname van jodide als de productie en uitscheiding van 
schildklierhormoon door de schildklier worden gereguleerd door het schildklier 
stimulerend hormoon (TSH). Dit hormoon wordt geproduceerd door de hypofyse. 
Echter, het grootste deel van de biologisch actieve vorm van schildklierhormoon, het 
T3l wordt, door middel van een monodejoderingsreactie, uit T4 gevormd in de perifere 
weefsels. Voor deze reactie zijn dejoderende enzymen verantwoordelijk; type I 
monodejodase (ID-I) in de lever en nieren, en type II monodejodase (ID-II) in het 
centraal zenuwstelsel en bruin vetweefsel. De concentratie van T4 en T3 in de diverse 
weefsels verschilt, evenals de bijdrage van de hoeveelheid T3 welke lokaal is gevormd 
uit T4. Een groot deel van de T3, welke lokaal in de lever is gevormd, wordt afgegeven 
aan de circulatie, terwijl lokaal gevormd T3 in de hersenen en het cerebellum 
voornamelijk lokaal gebruikt wordt. 
De productie, de verdeling en het transport van schildklierhormoon worden beïïnvloed 
door verschillende (patho)fysiologische omstandigheden. In deze studie hebben we ons 
geconcentreerd op de effecten van zwangerschap op het schildklierhormoon-
metabolisme van de moeder. Het is algemeen bekend dat schildklierhormoon van groot 
belang is voor een normale ontwikkeling van de foetus, met name van het centraal 
zenuwstelsel. Tijdens deze ontwikkeling levert schildklierhormoon van de moeder, 
zowel voor als na de start van de foetale schildklierfunctie, een bijdrage aan de foetale 
schildklierhormoonpools. Een ontoereikende productie van schildklierhormoon door de 
moeder tijdens de zwangerschap kan resulteren in permanente hersenbeschadiging 
van het nageslacht. In de rat zijn de concentraties van T4 en T3 in het plasma en de 
weefsels van de moeder aan het einde van de dracht verlaagd. Om meer inzicht te 
verkrijgen in de effecten van zwangerschap op de productie, de verdeling en het 
transport van T4 en T3 in de moeder, hebben we in niet-drachtige ratten en ratten aan 
het einde van de draagtijd experimenten uitgevoerd waarbij het kinetische gedrag van 
T4 en T3 is bepaald (hoofdstuk 2). De ratten ontvingen een eenmalige injectie van 
[125I]T4 en [131I]T3, waarna gedurende 24 uur, op vastgestelde tijdstippen bloedmonsters 
werden genomen. Fysiologische parameters van productie, transport, verdeling en 
metabolisme van T4 en T3 werden geschat met behulp van een drie-komparti-
mentenmodel. 
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In dit model kunnen drie kompartimenten worden onderscheiden: 1. het plasma; 2. een 
snel kompartiment; en 3. een langzaam kompartiment. Lever en nieren worden 
beschouwd als de belangrijkste componenten van het snelle kompartiment, terwijl de 
huid, spieren en hersenen tot het langzame kompartiment behoren. In de drachtige rat 
zijn, aan het einde van de dracht, de productie van de verdeling van T4 niet veranderd. 
Het transport van T4 van het plasma naar het snelle kompartiment was meer dan 
verdrievoudigd, terwijl het transport van het plasma naar het langzame kompartiment 
constant gebleven was. Wij veronderstellen dat in de rat, aan het einde van de dracht, 
het beschikbare T4, door middel van een zeer snel transport, wordt verdeeld tussen de 
moeder en de foetussen. Deze hypothese is gebaseerd op het feit dat het 
onwaarschijnlijk lijkt dat in de drachtige rat het transport van T4 naar de lever en de 
nieren van de moeder, welke als belangrijkste componenten van het snelle 
kompartiment beschouwd worden, in deze mate is toegenomen. Dit wordt bevestigd 
door de resultaten van studies waarbij ratten continu een infuus met [125I]T4 en [131I]T3 
ontvingen totdat in alle organen een evenwichtssituatie bereikt was. Dit houdt in dat de 
verhouding radioactief hormoon en endogeen hormoon in het hele lichaam gelijk is. Met 
behulp van deze methode is het mogelijk om de concentraties van T4 en T3, de relatieve 
bijdrage van T3 afkomstig uit het plasma ten opzichte van lokaal gevormd T3, de 
sekretie van T4 en T3 door de schildklier en de plasma/weefsel ratios in de verschillende 
weefsels te berekenen. En inderdaad, het transport van T4 naar lever en nieren, en 
bijna alle andere organen was verminderd. De onveranderde productie van T4 wijst erop 
dat T4 wordt getransporteerd naar een ander kompartiment. Wij gaan ervan uit dat dit 
de placentas plus de foetussen zijn. In onze experimenten kon dit kompartiment niet 
gemeten worden. De snelheid waarmee T3 in het plasma verschijnt blijft constant in de 
drachtige rat. Dit wordt bereikt door middel van een toename in de sekretie van T3 door 
de schildklier en een afname in de hoeveelheid lokaal gevormd T3. De hoeveelheid T3 
die vanuit het plasma naar de lever, nieren, bruin vet en hypofyse getransporteerd 
wordt is afgenomen. Zowel de ID-I activiteit in de lever als de ID-II activiteit in de 
hersenen is toegenomen tijdens de dracht. Echter, dit heeft geen toename van de lokale 
omzetting van T4 naar T3 in deze weefsels tot resultaat. In de lever blijft de bijdrage van 
lokaal gevormd T3 gelijk, terwijl in de hersenen zelfs een verlaging wordt gevonden. Dit 
kan verklaard worden doordat de beschikbaarheid van T4 in de weefsels van de moeder 
ontoereikend is. Het transport van T4 naar de placentas plus foetussen resulteert 
indirekt in een tekort aan T3 in de organen van de moeder. 
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We kunnen concluderen dat zwangerschap het schildklierhormoonmetabolisme van de 
moeder beïnvloedt. De moeder moet de beschikbare schildklierhormonen, vooral T4, 
met de foetussen delen. 
Voor de synthese van schildklierhormoon is jodide een onmisbaar element. In de rat is 
de foetale schildklier vanaf dag 18 van de dracht in staat om schildklierhormoon te 
produceren. Jodide wordt via de placenta van de bloedsomloop van de moeder naar 
de foetale bloedsomloop getransporteerd. In hoofdstuk 4 hebben we de opname van 
jodide door de schildklier van de moeder gemeten, terwijl een schatting is gemaakt van 
de opname van jodide door de foetale schildklier. De in vivo opname van 125l door de 
schildklier werd gedurende vier uur onafgebroken gemeten. Door gebruik te maken van 
de specifieke activiteit van jodide in de urine waren we in staat om de hoeveelheid 
jodide opgenomen door de schildklier te berekenen. Zwangerschap had een kleine 
afname van de hoeveelheid jodide welke door de schildklier van de moeder werd 
opgenomen tot resultaat. Op dag 20 van de dracht was de foetale schildklier in staat 
om jodide te concentreren. Het verschil in opgenomen hoeveelheid jodide door de 
schildklier van de moeder, vergeleken met de niet-drachtige situatie, kan echter niet 
volledig worden toegeschreven aan het transport van jodide naar de foetussen en/of de 
melkklieren. De daling in de opname van jodide door de schildklier van de moeder heeft 
geen gevolgen voor de productie van schildklierhormoon door de schildklier. 
Jodiumdeficiëntie kan een verstoorde fysische en mentale ontwikkeling tot gevolg 
hebben. In grote populaties in de wereld is de inname van jodium marginaal. Daarom 
is in onze experimenten gekozen voor het toebrengen van een marginale jodium-
deficiëntie, in plaats van de veel vaker gebruikte ernstige jodiumdeficiëntie. We hebben 
de effecten van marginale jodiumdeficiëntie op het metabolisme van jodide (opname 
van jodide door de schildklier; hoofdstuk 4) en het metabolisme van T4 en T3 (kinetiek 
experimenten; hoofstuk 5) in de drachtige rat, aan het einde van de draagtijd, 
bestudeerd. De hoeveelheid jodide opgenomen door de schildklier van de moeder werd 
niet beïnvloed door marginale jodiumdeficiëntie. De afname in de jodideconcentratie in 
het plasma werd gecompenseerd door een toename in de klaring door de schildklier. 
Een dergelijke compensatie werd niet gevonden in de foetussen; de opname van jodide 
door de foetale schildklier was gehalveerd tijdens marginale jodiumdeficiëntie. Zowel 
in drachtige als niet-drachtige ratten bleven de concentraties van T4 en T3 in het plasma 
onveranderd tijdens marginale jodiumdeficiëntie. Zowel de snelheid waarmee T4 werd 
geproduceerd als de snelheid waarmee T4 uit het plasma werd geklaard namen af. 
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In niet-drachtige ratten werden geen effecten van marginale jodiumdeficiëntie op de 
hoeveelheid T4 in de diverse kompartimenten en de snelheden van het transport van 
T4 gevonden. Marginale jodiumdeficiëntie resulteerde in de drachtige rat in een sterke 
daling van het transport van T4 van het plasma naar het snelle kompartiment. Voor T3 
werd een toename in de snelheid van productie en de snelheid van klaring uit het 
plasma gevonden in niet-drachtige, maginaal jodiumdeficiënte rat, terwijl deze 
parameters lichtelijk waren afgenomen in de drachtige rat. Marginale jodiumdeficiëntie 
had een afname van 50 % in de snelheid van transport van T3 tussen het plasma en het 
snelle kompartiment in de drachtige rat tot gevolg. De activiteit van ID-I in de lever was 
toegenomen tijdens marginale jodiumdeficiëntie in zowel niet-drachtige als drachtige 
ratten. 
Gebaseerd op de resultaten van de schildklierhormoonstudies in normale, drachtige 
ratten (hoofdstuk 2 en 3) veronderstellen wij dat tijdens marginale jodiumdeficiëntie de 
hoeveelheid T4 van de moeder, welke beschikbaar is voor de foetussen, verminderd is. 
Samen met de daling in de opname van jodide door de foetale schildklier, kan dit leiden 
tot verlaagde schildklierhormoonniveaus, afkomstig van zowel moeder als foetus, in de 
foetale organen. In dit geval zal marginale jodiumdeficiëntie negatieve effecten hebben 
op de ontwikkeling van de foetussen, in het bijzonder van de hersenen. 
Hypothyreoïdie van de moeder is een andere situatie waarbij de ontwikkeling van de 
foetale hersenen irreversibel beïnvloed wordt. Door vrouwelijke ratten waarvan de 
schildklier met behulp van 131l kapot is gestraald twee verschillende dosissen T4 en T3 
toe te dienen, werden twee verschillende niveaus van hypothyreoïdie geïnduceerd. Het 
effect van hypothyreoïdie op het metabolisme van T4 en T3 in de drachtige rat wordt 
beschreven in hoofdstuk 6. In de diep hypothyreote dieren waren de concentraties van 
T4 en T3 in het plasma erg laag, terwijl in de milde hypothyreote dieren alleen de 
concentratie van T3 in het plasma verlaagd was. Zelfs tijdens deze milde vorm van 
hypothyreoïdie werden, in vergelijking met intacte, drachtige dieren, verregaande 
veranderingen in de snelheden van transport van T4 gevonden. Het transport van T4 
van het plasma naar het snelle kompartiment was afgenomen. Dus, het lijkt erop dat 
zelfs tijdens een milde hypothyreoïdie het transport van T4 naar de placentas plus 
foetussen is aangetast. 
Concluderend: zwangerschap heeft veranderingen in de schildklierhormoonstatus van 
de moeder tot gevolg. Ondanks een onveranderde productie van T4 door de schildklier 
is in alle organen van de moeder de concentratie van T4 verlaagd. Door het transport 
van T4 naar de placentas plus foetussen is minder T4 beschikbaar voor de moeder zelf. 
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Dit resulteert indirect in een tekort aan T3 in de meeste organen. Zowel bij marginale 
jodiumdeficiëntie als bij milde hypothyreoïdie van de moeder is het transport van T4 
naar de placentas plus foetussen verminderd. Tijdens marginale jodiumdeficiëntie is 
ook de beschikbaarheid van jodide voor synthese van schildklierhormoon door de 
foetale schildklier verlaagd. Deze veranderingen kunnen in de foetus uiteindelijk een 
aantasting van de ontwikkeling van het centrale zenuwstelsel tot gevolg hebben. 
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